Serotonin and brain development

International Review of Neurobiology

Volumn 59, Issue , 2004, Pages 111-174

  Sodhi, Monsheel S K ^a   Sanders Bush, Elaine ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN; SEROTONIN RECEPTOR; TRYPTOPHAN;

ANIMAL; ANIMAL MODEL; ANXIETY; AUTISM; BRAIN; BRAIN LEVEL; CHEMISTRY; CLASSIFICATION; DOWN SYNDROME; GROWTH, DEVELOPMENT AND AGING; HUMAN; LEARNING; METABOLISM; MOOD DISORDER; NERVE CELL PLASTICITY; PHYSIOLOGY; REVIEW; SCHIZOPHRENIA; STRESS; SYNAPSE;

ANIMALS; ANXIETY; AUTISTIC DISORDER; BRAIN; BRAIN CHEMISTRY; DOWN SYNDROME; HUMANS; LEARNING; MODELS, ANIMAL; MOOD DISORDERS; NEURONAL PLASTICITY; RECEPTORS, SEROTONIN; SCHIZOPHRENIA; SEROTONIN; STRESS; SYNAPSES; TRYPTOPHAN;

EID: 2342616173     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(04)59006-2     Document Type: Article

References (477)

1. AbiDargham, A., Laruelle, M., Charney, D., and Krystal, J. (1996). Serotonin and Schizophrenia: A review. Drugs Today 32, 171-185.
2. Abi-Dargham, A., Laruelle, M., Lipska, B., Jaskiw, G. E., Wong, D. T., Robertson, D. W., Weinberger, D. R., and Kleinman, J. E. (1993). Serotonin 5-HT3 receptors in schizophrenia: A postmortem study of the amygdala. Brain Res. 616, 53-57.
3. Aghajanian, G. K. (1994). Electrophysiological studies on the actions of hallucinogenic drugs at 5-HT2 receptors in rat brain. NIDA Res. Monogr. 146, 183-202.
4. Aghajanian, G. K., and Marek, G. J. (1999). Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release. Brain Res. 825, 161-171.
5. Alves, S. E., Hoskin, E., Lee, S. J., Brake, W. G., Ferguson, D., Luine, V., Allen, P. B., Greengard, P., and McEwen, B. S. (2002). Serotonin mediates CA1 spine density but is not crucial for ovarian steroid regulation of synaptic plasticity in the adult rat dorsal hippocampus. Synapse 45, 143-151.
6. Arango, V., Underwood, M. D., and Mann, J. J. (1997). Postmortem findings in suicide victims: Implications for in vivo imaging studies. Ann. N. Y. Acad. Sci. 836, 269-287.
7. Archer, T., Ogren, S. O., and Ross, S. B. (1982). Serotonin involvement in aversive conditioning: Reversal of the fear retention deficit by long-term p-chloroamphetamine but not p-chlorophenylalanine. Neurosci. Lett. 34, 75-82.
8. Archer, T., Ogren, S. O., Ross, S. B., and Magnusson, O. (1984). Retention deficits induced by acute p-chloroamphetamine following fear conditioning in the rat. Psychopharmacology (Berl.) 82, 14-19.
9. Arranz, M., Collier, D., Sodhi, M., Ball, D., Roberts, G., Price, J., Sham, P., and Kerwin, R. (1995). Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet 346, 281-282.
10. Arranz, M. J., Collier, D. A., Munro, J., Sham, P., Kirov, G., Sodhi, M., Roberts, G., Price, J., and Kerwin, R. W. (1996). Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine. Neurosci. Lett. 217, 177-178.
11. Arranz, M. J., Munro, J., Owen, M. J., Spurlock, G., Sham, P. C., Zhao, J., Kirov, G., Collier, D. A., and Kerwin, R. W. (1998). Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine. Mol. Psychiat. 3, 61-66.
12. Asberg, M. (1997). Neurotransmitters and suicidal behavior: The evidence from cerebrospinal fluid studies. Ann. N. Y. Acad. Sci. 836, 158-181.
13. Audenaert, K., Van Laere, K., Dumont, F., Siegers, G., Mertens, J., van Heeringen, C., and Dierckx, R. A. (2001). Decreased frontal serotonin 5-HT 2a receptor binding index in deliberate self-harm patients. Eur. J. Nuclear Med. 28, 175-182.
14. Aylward, E. H., Minshew, N. J., Goldstein, G., Honeycutt, N. A., Augustine, A. M., Yates, K. O., Barta, P. E., and Pearlson, G. D. (1999). MRI volumes of amygdala and hippocampus in non-mentally retarded autistic adolescents and adults. Neurology 53, 2145-2150.
15. Ayres, A. J., and Tickle, L. S. (1980). Hyper-responsivity to touch and vestibular stimuli as a predictor of positive response to sensory integration procedures by autistic children. Am. J. Occup. Ther. 34, 375-381.
16. Azmitia, E. C. (1999). Serotonin neurons, neuroplasticity, and homeostasis of neural tissue. Neuropsychopharmacology 21, 33S-45S.
17. Azmitia, E. C. (2001). Modern views on an ancient chemical: Serotonin effects on cell proliferation, maturation, and apoptosis. Brain Res. Bull. 56, 413-424.
18. Azmitia, E. C., and Gannon, P. J. (1986). The primate serotonergic system: A review of human and animal studies and a report on Macaca fascicularis. Adv. Neurol. 43, 407-468.
19. Azmitia, E. C., Rubinstein, V. J., Strafaci, J. A., Rios, J. C., and Whitaker-Azmitia, P. M. (1995). 5-HT1A agonist and dexamethasone reversal of para-chloroamphetamine induced loss of MAP-2 and synaptophysin immunoreactivity in adult rat brain. Brain Res. 677, 181-192.
20. Bakish, D., Lapierre, Y. D., Weinstein, R., Klein, J., Wiens, A., Jones, B., Horn, E., Browne, M., Bourget, D., Blanchard, A., et al. (1993). Ritanserin, imipramine, and placebo in the treatment of dysthymic disorder. J. Clin. Psychopharmacol. 13, 409-414.
21. Banasr, M., Hery, M., Brezun, J. M., and Daszuta, A. (2001). Serotonin mediates oestrogen stimulation of cell proliferation in the adult dentate gyrus. Eur. J. Neurosci. 14, 1417-1424.
22. Barnes, N. M., and Sharp, T. (1999). A review of central 5-HT receptors and their function. Neuropharmacology 38, 1083-1152.
23. Bar-Peled, O., Gross-Isseroff, R., Ben-Hur, H., Hoskins, I., Groner, Y., and Biegon, A. (1991a). Fetal human brain exhibits a prenatal peak in the density of serotonin 5-HT1A receptors. Neurosci. Lett. 127, 173-176.
24. Bar-Peled, O., Israeli, M., Ben-Hur, H., Hoskins, I., Groner, Y., and Biegon, A. (1991b). Developmental pattern of muscarinic receptors in normal and Down's syndrome fetal brain: An autoradiographic study. Neurosci. Lett. 133, 154-158.
25. Bayliss, D. A., Viana, F., Talley, E. M., and Berger, A. J. (1997). Neuromodulation of hypoglossal motoneurons: Cellular and developmental mechanisms. Respir. Physiol. 110, 139-150.
26. Beaumont, V., and Zucker, R. S. (2000). Enhancement of synaptic transmission by cyclic AMP modulation of presynaptic 1h channels. Nature Neurosci. 3, 133-141.
27. Becker, L. E., Armstrong, D. L., and Chan, F. (1986). Dendritic atrophy in children with Down's syndrome. Ann. Neurol. 20, 520-526.
28. Benes, F. M., Taylor, J. B., and Cunningham, M. G. (2000). Convergence and plasticity of monoaminergic systems in the medial prefrontal cortex during the postnatal period: Implications for the development of psychopathology. Cent. Cortex 10, 1014-1027.
29. Bennett-Clarke, C. A., Hankin, M. H., Leslie, M. J., Chiaia, N. L., and Rhoades, R. W. (1994). Patterning of the neocortical projections from the raphe nuclei in perinatal rats: Investigation of potential organizational mechanisms. J. Comp. Neurol. 348, 277-290.
30. Bersani, G., Pozzi, F., Marini, S., Grispini, A., Pasini, A., and Ciani, N. (1991). 5-HT2 receptor antagonism in dysthymic disorder: A double-blind placebo-controlled study with ritanserin. Acta Psychiatr. Scand. 83, 244-248.
31. Betancur, C., Corbex, M., Spielewoy, C., Philippe, A., Laplanche, J. L., Launay, J. M., Gillberg, C., Mouren-Simeoni, M. C., Hamon, M., Giros, B., Nosten-Bertrand, M., and Leboyer, M. (2002). Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder. Mol. Psychiat. 7, 67-71.
32. Biegon, A., Essar, N., Israeli, M., Elizur, A., Bruch, S., and Bar-Nathan, A. A. (1990). Serotonin 5-HT2 receptor binding on blood platelets as a state dependent marker in major affective disorder. Psychopharmacology (Berl.) 102, 73-75.
33. Blatt, G. J., Chen, J. G., Rosene, D. L., Volicer, L., and Galler, J. R. (1994). Prenatal protein malnutrition effects on the serotonergic system in the hippocampal formation: An immunocytochemical, ligand binding, and neurochemical study. Brain Res. Bull. 34, 507-518.
34. Bliss, T. V., and Gardner-Medwin, A. R. (1973). Long-lasting potentiation of synaptic transmission in the dentate area of the unanaestetized rabbit following stimulation of the perforant path. J. Physiol. 232, 357-374.
35. Blue, M. E., Erzurumlu, R. S., and Jhaveri, S. (1991). A comparison of pattern formation by thalamocortical and serotonergic afferents in the rat barrel field cortex. Cereb. Cortex 1, 380-389.
36. Boswell, C. A., Majno, G., Joris, I., and Ostrom, K. A. (1992). Acute endothelial cell contraction in vitro: A comparison with vascular smooth muscle cells and fibroblasts. Microvasc. Res. 43, 178-191.
37. Boullin, D. J., Coleman, M., and O'Brien, R. A. (1970). Abnormalities in platelet 5-hydroxytryptamine efflux in patients with infantile autism. Nature 226, 371-372.
38. Boullin, D. J., Coleman, M., O'Brien, R. A., and Rimland, B. (1971). Laboratory predictions of infantile autism based on 5-hydroxytryptamine efflux from blood platelets and their correlation with the Rimland E-2 score. J. Autism Child. Schizophr. 1, 63-71.
39. Boullin, D. J., and O'Brien, R. A. (1971). Abnormalities of 5-hydroxytryptamine uptake and binding by blood platelets from children with Down's syndrome. J. Physiol. 212, 287-297.
40. Bradley, P. B., Feniuk, W., Fozard, J. R., Humphrey, P. P., Middlemiss, D. N., Mylecharane, E. J., Richardson, B. P., and Saxena, P. R. (1986). Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25, 563-576.
41. Bray, G. A. (2000). A concise review on the therapeutics of obesity. Nutrition 16, 953-960.
42. Breier, A. (1989). A. E. Bennett award paper. Experimental approaches to human stress research: Assessment of neurobiological mechanisms of stress in volunteers and psychiatric patients. Biol. Psychiat. 26, 438-462.
43. Breier, A. (1995). Serotonin, schizophrenia and antipsychotic drug-action. Schizophr. Res. 14, 187-202.
44. Brezun, J. M., and Daszuta, A. (1999). Serotonin depletion in the adult rat produces differential changes in highly polysialylated form of neural cell adhesion molecule and tenascin-G immunoreactivity. J. Neurosci. Res. 55, 54-70.
45. Brismar, T. (1995). Physiology of transformed glial cells. Glia 15, 231-243.
46. Broydell, M., Mazzuca, D. M., Abidi, F., Kudo, P. A., and Lo, T. C. (1997). Involvement of the GLUT 3 transporter in myogenic regulation. Biochem. Mol. Biol. Int. 43, 847-866.
47. Buitelaar, J. K., and Willemsen-Swinkels, S. H. (2000). Autism: Current theories regarding its pathogenesis and implications for rational pharmacotherapy. Paediatr. Drugs. 2, 67-81.
48. Bulik, C. M., Prescott, C. A., and Kendler, K. S. (2001). Features of childhood sexual abuse and the development of psychiatric and substance use disorders. Br. J. Psychiat. 179, 444-149.
49. Buonomano, D. V., and Merzenich, M. M. (1995). Temporal information transformed into a spatial code by a neural network with realistic properties. Science 267, 1028-1030.
50. Burnet, P. W., Eastwood, S. L., and Harrison, P. J. (1996). 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Neuropsychopharmacology 15, 442-155.
51. Burnet, P. W., Sharp, T., LeCorre, S. M., and Harrison, P. J. (1999). Expression of 5-HT receptors and the 5-HT transporter in rat brain after electroconvulsive shock. Neurosci. Lett. 277, 79-82.
52. Burns, C. M., Chu, H., Rueter, S. M., Hutchinson, L. K., Canton, H., Sanders-Bush, E., and Emeson, R. B. (1997). Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 387, 303-308.
53. 2+/calmodulin-dependent kinase II in prefrontal cortical pyramidal neurons. J. Biol. Chem. 277, 36553-36562.
54. Calabrese, J. R., Kimmel, S. E., Woyshville, M. J., Rapport, D. J., Faust, C. J., Thompson, P. A., and Meltzer, H. Y. (1996). Clozapine for treatment-refractory mania. Am. J. Psychiat. 153, 759-764.
55. Calabrese, J. R., Meltzer, H. Y., and Markovitz, P. J. (1991). Clozapine prophylaxis in rapid cycling bipolar disorder. J. Clin. Psychopharmacol. 11, 396-397.
56. Cannon, M., Jones, P., Gilvarry, C., Rifkin, L., McKenzie, K., Foerster, A., and Murray, R. M. (1997). Premorbid social functioning in schizophrenia and bipolar disorder: Similarities and differences. Am. J. Psychiat. 154, 1544-1550.
57. Cases, O., Vitalis, T., Seif, I., De Maeyer, E., Sotelo, G., and Gaspar, P. (1996). Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period. Neuron 16, 297-307.
58. Ceulemans, D. L., Hoppenbrouwers, M. L., Gelders, Y. G., and Reyntjens, A. J. (1985). The influence of ritanserin, a serotonin antagonist, in anxiety disorders: A double-blind placebo-controlled study versus lorazepam. Pharmacopsychiatry 18, 303-305.
59. Chadwick, D., Jenner, P., and Reynolds, E. H. (1977). Serotonin metabolism in human epilepsy: Influence of anticonvulsant drugs. Epilepsia 18, 288.
60. Charney, D. S., Heninger, G. R., Reinhard, J. F., Jr., Sternberg, D. E., and Hafstead, K. M. (1982). The effect of intravenous L-tryptophan on prolactin and growth hormone and mood in healthy subjects. Psychopharmacology (Berl.) 77, 217-222.
61. Charney, D. S., Menkes, D. B., and Heninger, G. R. (1981). Receptor sensitivity and the mechanism of action of antidepressant treatment: Implications for the etiology and therapy of depression. Arch. Gen. Psychiat. 38, 1160-1180.
62. Chen, L., Hamaguchi, K., Ogawa, M., Hamada, S., and Okada, N. (1994). PCPA reduces both monoaminergic afferents and nonmonoaminergic synapses in the cerebral cortex. Neurosci. Res. 19, 111-115.
63. 2+ influx in rat basolateral amygdala via 5-HT1A receptors. Eur. J. Neurosci. 10, 2163-2172.
64. Chiaia, N. L., Fish, S. E., Bauer, W. R., Figley, B. A., Eck, M., Bennett-Clarke, C. A., and Rhoades, R. W. (1994). Effects of postnatal blockade of cortical activity with tetrodotoxin upon the development and plasticity of vibrissa-related patterns in the somatosensory cortex of hamsters. Somatosens. Motil. Res. 11, 219-228.
65. Choi, D. S., Kellermann, O., Richard, S., Colas, J. F., Bolanos-Jimenez, F., Tournois, C., Launay, J. M., and Maroteaux, L. (1998). Mouse 5-HT2B receptor-mediated serotonin trophic functions. Ann. N. Y. Acad. Sci. 861, 67-73.
66. Choi, D. S., Ward, S. J., Messaddeq, N., Launay, J. M., and Maroteaux, L. (1997). 5-HT2B receptor-mediated serotonin morphogenetic functions in mouse cranial neural crest and myocardiac cells. Development 124, 1745-1755.
67. Chua, S. E., and Murray, R. M. (1996). The neurodevelopmental theory of schizophrenia: Evidence concerning structure and neuropsychology. Ann. Med. 28, 547-555.
68. Chubakov, A. R., Gromova, E. A., Konovalov, G. V., Sarkisova, E. F., and Chumasov, E. I. (1986). The effects of serotonin on the morpho-functional development of rat cerebral neocortex in tissue culture. Brain Res. 369, 285-297.
69. Chubakov, A. R., Tsyganova, V. G., and Sarkisova, E. F. (1993). The stimulating influence of the raphe nuclei on the morphofunctional development of the hippocampus during their combined cultivation. Neurosci. Behav. Physiol. 23, 271-276.
70. Chugani, D. C., and Chugani, H. T. (2003). Does serotonin have trophic effects in temporal lobe epilepsy? Neurology 60, 736-737.
71. Chugani, D. C., Muzik, O., Rothermel, R., Behen, M., Chakraborty, P., Mangner, T., da Silva, E. A., and Chugani, H. T. (1997). Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann. Neurol. 42, 666-669.
72. Claustre, Y., Rouquier, L., and Scatton, B. (1988). Pharmacological characterization of serotonin-stimulated phosphoinositide turnover in brain regions of the immature rat. J. Pharmacol. Exp. Ther. 244, 1051-1056.
73. Cleare, A. J., and Bond, A. J. (1995). The effect of tryptophan depletion and enhancement on subjective and behavioural aggression in normal male subjects. Psychopharmacology (Berl.) 118, 72-81.
74. Conn, P. J., and Sanders-Bush, E. (1984). Selective 5HT-2 antagonists inhibit serotonin stimulated phosphatidylinositol metabolism in cerebral cortex. Neuropharmacology 23, 993-996.
75. Conn, P. J., and Sanders-Bush, E. (1986a). Biochemical characterization of serotonin stimulated phosphoinositide turnover. Life Sci. 38, 663-669.
76. Conn, P. J., and Sanders-Bush, E. (1986b). Regulation of serotonin-stimulated phosphoinositide hydrolysis: Relation to the serotonin 5-HT-2 binding site. J. Neurosci. 6, 3669-3675.
77. Conn, P. J., and Sanders-Bush, E. (1987). Central serotonin receptors: Effector systems, physiological roles and regulation. Psychopharmacology (Berl.) 92, 267-277.
78. Conn, P. J., Sanders-Bush, E., Hoffman, B. J., and Hartig, P. R. (1986). A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover. Proc. Natl. Acad. Sci. USA 83, 4086-4088.
79. Cook, E. H., and Leventhal, B. L. (1996). The serotonin system in autism. Curr. Opin. Pediatr. 8, 348-354.
80. Coppen, A., Shaw, D. M., Herzberg, B., and Maggs, R. (1967). Tryptophan in the treatment of depression. Lancet 2, 1178-1180.
81. Coppen, A. J., and Doogan, D. P. (1988). Serotonin and its place in the pathogenesis of depression. J. Clin. Psychiat. 49(Suppl.), 4-11.
82. Craddock, N., and Jones, I. (1999). Genetics of bipolar disorder. J. Med. Genet. 36, 585-594.
83. Craddock, N., and Jones, I. (2001). Molecular genetics of bipolar disorder. Br. J. Psychiat. Suppl. 41, s128-s133.
84. Crossland, N. (2001). Expression of the 5-HT2C receptor gene in schizophrenia. G6R DPhil Oxford, 51-164-111.
85. Crow, T. J., Ferrier, I. N., and Johnstone, E. C. (1986). The two-syndrome concept and neuroendocrinology of schizophrenia. Psychiat. Clin. North Am. 9, 99-113.
86. Cynader, M., Timney, B. N., and Mitchell, D. E. (1980). Period of susceptibility of kitten visual cortex to the effects of monocular deprivation extends beyond six months of age. Brain Res. 191, 545-550.
87. Dailey, J. W., Yan, Q. S., Mishra, P. K., Burger, R. L., and Jobe, P. C. (1992). Effects of fluoxetine on convulsions and on brain-serotonin as detected by microdialysis in genetically epilepsy-prone rats. J. Pharmacol. Exp. Ther. 260, 533-540.
88. D'Amato, R. J., Blue, M. E., Largent, B. L., Lynch, D. R., Ledbetter, D. J., Molliver, M. E., and Snyder, S. H. (1987). Ontogeny of the serotonergic projection to rat neocortex: Transient expression of a dense innervation to primary sensory areas. Proc. Natl. Acad. Sci. USA 84, 4322-1326.
89. Daval, G., Verge, D., Becerril, A., Gozlan, H., Spampinato, U., and Hamon, M. (1987). Transient expression of 5-HT1A receptor binding sites in some areas of the rat CNS during postnatal development. Int. J. Dev. Neurosci. 5, 171-180.
90. Davis, E., Fennoy, I., Laraque, D., Kanem, N., Brown, G., and Mitchell, J. (1992). Autism and developmental abnormalities in children with perinatal cocaine exposure. J. Natl. Med. Assoc. 84, 315-319.
91. de Boer, T. (1996). The pharmacologic profile of mirtazapine. J. Clin. Psychiat. 57(Suppl. 4), 19-25.
92. de Boer, T. H., Nefkens, F., van Helvoirt, A., and van Delft, A. M. (1996). Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan. J. Pharmacol. Exp. Ther. 277, 852-860.
93. Deahl, M., and Trimble, M. (1991). Serotonin reuptake inhibitors, epilepsy and myoclonus. Br. J. Psychiat. 159, 433-435.
94. Dean, B., and Hayes, W. (1996). Decreased frontal cortical serotonin(2A) receptors in schizophrenia. Schizophr. Res. 21, 133-139.
95. Dean, B., Hayes, W., Opeskin, K., Naylor, L., Pavey, G., Hill, C., Keks, N., and Copolov, D. L. (1996). Serotonin2 receptors and the serotonin transporter in the schizophrenic brain. Behav. Brain Res. 73, 169-175.
96. 3H]Paroxetine binding is altered in the hippocampus but not the frontal cortex or caudate nucleus from subjects with schizophrenia. J. Neurochem. 64, 1197-1202.
97. DeFelipe, J., Hendry, S. H., Hashikawa, T., and Jones, E. G. (1991). Synaptic relationships of serotonin-immunoreactive terminal baskets on GABA neurons in the cat auditory cortex. Cereb. Cortex 1, 117-133.
98. Del Angel-Meza, A. R., Ramirez-Cortes, L., Adame-Gonzalez, I. G., Gonzalez Burgos, I., and Beas-Zarate, C. (2002). Cerebral GABA release and GAD activity in protein- and tryptophan-restricted rats during development. Int. J. Dev. Neurosci. 20, 47-54.
99. Delgado, P. L., Charney, D. S., Price, L. H., Aghajanian, G. K., Landis, H., and Heninger, G. R. (1990). Serotonin function and the mechanism of antidepressant action: Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch. Gen. Psychiat. 47, 411-418.
100. Dinan, T. G. (1996). Noradrenergic and serotonergic abnormalities in depression: Stress-induced dysfunction? J. Clin. Psychiat. 57(Suppl. 4), 14-18.
101. Dinerman, J. L., Dawson, T. M., Schell, M. J., Snowman, A., and Snyder, S. H. (1994). Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: Implications for synaptic plasticity. Proc. Natl. Acad. Sci. USA 91, 4214-4218.
102. Ding, D., Toth, M., Zhou, Y., Parks, C., Hoffman, B. J., and Shenk, T. (1993). Glial cell-specific expression of the serotonin 2 receptor gene: Selective reactivation of a repressed promoter. Brain Res. Mol. Brain Res. 20, 181-191.
103. Dixon, D., and Atwood, H. L. (1989). Conjoint action of phosphatidylinositol and adenylate cyclase systems in serotonin-induced facilitation at the crayfish neuromuscular junction. J. Neurophysiol. 62, 1251-1259.
104. Doraiswamy, P. M. (2003). The role of the N-methyl-d-aspartate receptor in Alzheimer's disease: Therapeutic potential. Curr. Neurol. Neurosci. Rep. 3, 373-378.
105. Dracheva, S., Elhakem, S. L. et al. (2003). RNA editing and alternative splicing of human serotonin 2C receptor in schizophrenia. J. Neurochem. 87, 1402-1412.
106. Drevets, W. G., Frank, E., Price, J. G., Kupfer, D. J., Holt, D., Greer, P. J., Huang, Y., Gautier, C., and Mathis, G. (1999). PET imaging of serotonin 1A receptor binding in depression. Biol. Psychiat. 46, 1375-1387.
107. Dyck, R. H., and Cynader, M. S. (1993a). Autoradiographic localization of serotonin receptor subtypes in cat visual cortex: Transient regional, laminar, and columnar distributions during postnatal development. J. Neurosci. 13, 4316-4338.
108. Dyck, R. H., and Cynader, M. S. (1993b). An interdigitated columnar mosaic of cytochrome oxidase, zinc, and neurotransmitter-related molecules in cat and monkey visual cortex. Proc. Natl. Acad. Sci. USA 90, 9066-9069.
109. East, S. Z., Burnet, P. W., Kerwin, R. W., and Harrison, P. J. (2002a). An RT-PCR study of 5-HT(6) and 5-HT(7) receptor mRNAs in the hippocampal formation and prefrontal cortex in schizophrenia. Schizophr. Res. 57, 15-26.
110. East, S. Z., Burnet, P. W., Leslie, R. A., Roberts, J. C., and Harrison, P. J. (2002b). 5-HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: Autoradiographic studies with [125I]SB-258585. Synapse 45, 191-199.
111. Eastwood, S. L., Burnet, P. W., Gittins, R., Baker, K., and Harrison, P. J. (2001). Expression of serotonin 5-HT(2A) receptors in the human cerebellum and alterations in schizophrenia. Synapse 42, 104-114.
112. Eddahibi, S., Fabre, V., Boni, G., Martres, M. P., Raffestin, B., Hamon, M., and Adnot, S. (1999). Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells: Relationship with the mitogenic action of serotonin. Crit. Res. 84, 329-336.
113. Edwards, H. E., Burnham, W. M., and MacLusky, N. J. (1999). Testosterone and its metabolites affect after discharge thresholds and the development of amygdala kindled seizures. Brain Res. 838, 151-157.
114. Eison, A. S., Yocca, F. D., and Gianutsos, G. (1991). Effect of chronic administration of antidepressant drugs on 5-HT2-mediated behavior in the rat following noradrenergic or serotonergic denervation. J. Neural Transm. Gen. Sect. 84, 19-32.
115. Eison, M. S. (1990). Serotonin: A common neurobiologic substrate in anxiety and depression. J. Clin. Psychopharmacol. 10, 26S-30S.
116. Ellenbogen, M. A., Young, S. N., Dean, P., Palmour, R. M., and Benkelfat, C. (1996). Mood response to acute tryptophan depletion in healthy volunteers: Sex differences and temporal stability. Neuropsychopharmacology 15, 465-474.
117. Enyeart, J. (1981). Cyclic AMP, 5-HT, and the modulation of transmitter release at the crayfish neuromuscular junction. J. Neurobiol. 12, 505-513.
118. Esterle, T. M., and Sanders-Bush, E. (1992). Serotonin agonists increase transferrin levels via activation of 5-HT1G receptors in choroid plexus epithelium. J. Neurosci. 12, 4775-4782.
119. Faber, K. M., and Haring, J. H. (1999). Synaptogenesis in the postnatal rat fascia dentata is influenced by 5-HT1a receptor activation. Brain Res. Dev. Brain Res. 114, 245-252.
120. Fair, S. A., Uezu, K., Creonte, T. A., Flood, J. F., and Morley, J. E. (2000). Modulation of memory processing in the cingulate cortex of mice. Pharmacol. Biochem. Behav. 65, 363-368.
121. Fatemi, S. H., Realmuto, G. M., Khan, L., and Thuras, P. (1998). Fluoxetine in treatment of adolescent patients with autism: A longitudinal open trial. J. Autism Dev. Disord. 28, 303-307.
122. Feighner, J., Targum, S. D., Bennett, M. E., Roberts, D. L., Kensler, T. T., D'Amico, M. F., and Hardy, S. A. (1998). A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression. J. Clin. Psychiat. 59, 246-253.
123. Feighner, J. P., and Boyer, W. F. (1989). Serotonin-1A anxiolytics: An overview. Psychopathology 22(Suppl. 1), 21-26.
124. Feinberg, I. (1982). Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence? J. Psychiat. Res. 17, 319-334.
125. Fendt, M., and Fanselow, M. S. (1999). The neuroanatomical and neurochemical basis of conditioned fear. Neurosci. Biobehav. Rev. 23, 743-760.
126. Fernandes, C., McKittrick, C. R., File, S. E., and McEwen, B. S. (1997). Decreased 5-HT1A and increased 5-HT2A receptor binding after chronic corticosterone associated with a behavioural indication of depression but not anxiety. Psychoneuroendocrinology 22, 477-491.
127. Flugge, G. (1995). Dynamics of central nervous 5-HT1A-receptors under psychosocial stress. J. Neurosci. 15, 7132-7140.
128. Flugge, G., Ahrens, O., and Fuchs, E. (1997). Monoamine receptors in the prefrontal cortex of Tupaja belangeri during chronic psychosocial stress. Cell Tissue Res. 288, 1-10.
129. Flugge, G., Kramer, M., Rensing, S., and Fuchs, E. (1998). 5HT1A-receptors and behaviour under chronic stress: Selective counteraction by testosterone. Eur. J. Neurosci. 10, 2685-2693.
130. Fone, K. G., Shalders, K., Fox, Z. D., Arthur, R., and Marsden, C. A. (1996). Increased 5-HT2C receptor responsiveness occurs on rearing rats in social isolation. Psychopharmacology (Berl.) 123, 346-352.
131. Foy, M. R., Xu, J., Xie, X., Brinton, R. D., Thompson, R. F., and Berger, T. W. (1999). 17beta-estradiol enhances NMDA receptor-mediated EPSPs and long-term potentiation. J. Neurophysiol. 81, 925-929.
132. Frankland, P. W., O'Brien, C., Ohno, M., Kirkwood, A., and Silva, A. J. (2001). Alpha-CaMKII-dependent plasticity in the cortex is required for permanent memory. Nature 411, 309-313.
133. Freedman, B., and Chapman, L. J. (1973). Early subjective experience in schizophrenic episodes. J. Abnorm. Psychol. 82, 46-54.
134. Fries, P., Fernandez, G., and Jensen, O. (2003). When neurons from memories. Trends Neurosci. 26, 123-124.
135. Fromm, G. H., Glass, J. D., and Chattha, A. S. (1977). Role of serotonin in petit mal epilepsy. Electroen. Clin. Neuro. 43, 297.
136. Frye, M. A., Ketter, T. A., Altshuler, L. L., Denicoff, K., Dunn, R. T., Kimbrell, T. A., Cora-Locatelli, G., and Post, R. M. (1998). Clozapine in bipolar disorder: Treatment implications for other atypical antipsychotics. J. Affect. Disord. 48, 91-104.
137. Fuster, J. M. (1985). The prefrontal cortex, mediator of cross-temporal contingencies. Hum. Neurobiol. 4, 169-179.
138. Fuster, J. M. (1991). The prefrontal cortex and its relation to behavior. Prog. Brain Res. 87, 201-211.
139. Gaddum, J. H., and Picarelli, Z. P. (1957). Two kinds of tryptamine receptor. Br. J. Pharmacol. 120, 134-139.
140. Garey, L. J., Ong, W. Y., Patel, T. S., Kanani, M., Davis, A., Mortimer, A. M., Barnes, T. R., and Hirsch, S. R. (1998). Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J. Neurol. Neurosurg. Psychiat. 65, 446-453.
141. Gedye, A. (1990). Dietary increase in serotonin reduces self-injurious behaviour in a Down's syndrome adult. J. Ment. Defic. Res. 34(Pt. 2), 195-203.
142. Gedye, A. (1991). Serotonergic treatment for aggression in a Down's syndrome adult showing signs of Alzheimer's disease. J. Ment. Defic. Res. 35(Pt. 3), 247-258.
143. Glantz, L. A., and Lewis, D. A. (2000). Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiat. 57, 65-73.
144. Glazewski, S., Giese, K. P., Silva, A., and Fox, K. (2000). The role of alpha-CaMKII autophosphorylation in neocortical experience-dependent plasticity. Nature Neurosci. 3, 911-918.
145. Glennon, R. A., Titeler, M., and McKenney, J. D. (1984). Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci. 35, 2505-2511.
146. Godridge, H., Reynolds, G. P., Czudek, C., Calcutt, N. A., and Benton, M. (1987). Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue. J. Neurol. Neurosurg. Psychiat. 50, 775-778.
147. Goldman-Rakic, P. S. (1987). Development of cortical circuitry and cognitive function. Child Dev. 58, 601-622.
148. Goldman-Rakic, P. S. (1994). Working memory dysfunction in schizophrenia. J. Neuropsychiat. Clin. Neurosci. 6, 348-357.
149. Goldman-Rakic, P. S. (1995). Architecture of the prefrontal cortex and the central executive. Ann. N. Y. Acad. Sci. 769, 71-83.
150. Gonzalez-Burgos, I., del Angel-Meza, A. R., Barajas-Lopez, G., and Feria-Velasco, A. (1996). Tryptophan restriction causes long-term plastic changes in corticofrontal pyramidal neurons. Int. J. Dev. Neurosci. 14, 673-679.
151. Good, M., Day, M., and Muir, J. L. (1999). Cyclical changes in endogenous levels of oestrogen modulate the induction of LTD and LTP in the hippocampal CA1 region. Eur. J. Neurosci. 11, 4476-4480.
152. Goudreau, J. L., Manzanares, J., Lookingland, K. J., and Moore, K. E. (1993). 5HT2 receptors mediate the effects of stress on the activity of periventricular hypophysial dopaminergic neurons and the secretion of alpha-melanocyte-stimulating hormone. J. Pharmacol. Exp. Ther. 265, 303-307.
153. Gould, E., Tanapat, P., McEwen, B. S., Flugge, G., and Fuchs, E. (1998). Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proc. Natl. Acad. Sci. USA 95, 3168-3171.
154. Gresch, P. J., Strickland, L. V., and Sanders-Bush, E. (2002). Lysergic acid diethylamide-induced Fos expression in rat brain: Role of serotonin-2A receptors. Neuroscience 114, 707-713.
155. Griebel, G., Misslin, R., Pawlowski, M., and Vogel, E. (1991). m-Chlorophenylpiperazine enhances neophobic and anxious behaviour in mice. Neuroreport. 2, 627-629.
156. Gross, C., Zhuang, X., Stark, K., Ramboz, S., Oosting, R., Kirby, L., Santarelli, L., Beck, S., and Hen, R. (2002). Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416, 396-400.
157. Gudelsky, G. A., and Yamamoto, B. K. (2003). Neuropharmacology and neurotoxicity of 3,4-methylenedioxymethamphetamine. Methods Mol. Med. 79, 55-73.
158. Gulesserian, T., Engidawork, E., Cairns, N., and Lubec, G. (2000). Increased protein levels of serotonin transporter in frontal cortex of patients with Down syndrome. Neurosci. Lett. 296, 53-57.
159. Gurevich, E. V., and Joyce, J. N. (1997). Alterations in the cortical serotonergic system in schizophrenia: A postmortem study. Biol. Psychiat. 42, 529-545.
160. Gurevich, I., Tamir, H. et al. (2002). Altered editing of serotonin 2G receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron 34, 349-356.
161. GuyGrand, B. (1995). Clinical studies with dexfenfluramine: From past to future. Obes. Res. 3, S491-S496.
162. Hafner, H. (2003). Gender differences in schizophrenia. Psychoneuroendocrinology 28(Suppl. 2), 17-54.
163. Halford, J. C. G. (2001). Pharmacology of appetite suppression: Implication for the treatment of obesity. Curr. Drug Targets. 2, 353-370.
164. Hamon, M., and Bourgoin, S. (1979). Ontogenesis of tryptophan transport in the rat brain. J. Neural Transm. Suppl. 93-105.
165. Hanson, D. R., Gottesman, I. I., and Heston, L. L. (1976). Some possible childhood indicators of adult schizophrenia inferred from children of schizophrenics. Br. J. Psychiat. 129, 142-154.
166. Harrison, P. J. (1995). On the neuropathology of schizophrenia and its dementia: Neurodevelopmental, neurodegenerative, or both? Neurodegeneration 4, 1-12.
167. Harrison, P. J. (1999a). Neurochemical alterations in schizophrenia affecting the putative receptor targets of atypical antipsychotics: Focus on dopamine (D1, D3, D4) and 5-HT2a receptors. Br. J. Psychiat. Suppl. 12-22.
168. Harrison, P. J. (1999b). The neuropathology of schizophrenia: A critical review of the data and their interpretation. Brain 122(Pt. 4), 593-624.
169. Harrison, P. J., and Burnet, P. W. (1997). The 5-HT2A (serotonin2A) receptor gene in the aetiology, pathophysiology and pharmacotherapy of schizophrenia. J. Psychopharmacol. 11, 18-20.
170. Harrison, P. J., and Geddes, J. R. (1996). Schizophrenia and the 5-HT2A receptor gene. Lancet 347, 1274.
171. Hashimoto, S., Inoue, T., and Koyama, T. (1996). Serotonin reuptake inhibitors reduce conditioned fear stress-induced freezing behavior in rats. Psychopharmacology (Berl.) 123, 182-186.
172. Hashimoto, S., Inoue, T., and Koyama, T. (1997). Effects of the co-administration of 5-HT1A receptor antagonists with an SSRI in conditioned fear stress-induced freezing behavior. Pharmacol. Biochem. Behav. 58, 471-475.
173. Hashimoto, T., Kitamura, N., Kajimoto, Y., Shirai, Y., Shirakawa, O., Mita, T., Nishino, N., and Tanaka, C. (1993). Differential changes in serotonin 5-HT1A and 5-HT2 receptor binding in patients with chronic schizophrenia. Psychopharmacology (Berl.) 112, S35-S39.
174. Hashimoto, T., Nishino, N., Nakai, H., and Tanaka, C. (1991). Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia. Life Sci. 48, 355-363.
175. Heal, D. J., Aspley, S., Prow, M. R., Jackson, H. C., Martin, K. F., and Cheetham, S. C. (1998). Sibutramine: A novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine. Int. J. Obesity 22, S18-S28.
176. Hedner, J., Lundell, K. H., Breese, G. R., Mueller, R. A., and Hedner, T. (1986). Developmental variations in CSF monoamine metabolites during childhood. Biol. Neonate. 49, 190-197.
177. Heisler, L. K., Chu, H. M., Brennan, T. J., Danao, J. A., Bajwa, P., Parsons, L. H., and Tecott, L. H. (1998a). Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc. Natl. Acad. Sci. USA 95, 15049-15054.
178. Heisler, L. K., Chu, H. M., and Tecott, L. H. (1998b). Epilepsy and obesity in serotonin 5-HT2C receptor mutant mice. Ann. N. Y. Acad. Sci. 861, 74-78.
179. Hendricks, T., Francis, N., Fyodorov, D., and Deneris, E. S. (1999). The ETS domain factor Pet-1 is an early and precise marker of central serotonin neurons and interacts with a conserved element in serotonergic genes. J. Neurosci. 19, 10348-10356.
180. Herdegen, T., and Leah, J. D. (1998). Inducible and constitutive transcription factors in the mammalian nervous system: Control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res. Brain Res. Rev. 28, 370-490.
181. Hernandez, I., and Sokolov, B. P. (2000). Abnormalities in 5-HT2A receptor mRNA expression in frontal cortex of chronic elderly schizophrenics with varying histories of neuroleptic treatment. J. Neurosci. Res. 59, 218-225.
182. Herrick-Davis, K., Grinde, E., and Niswender, C. M. (1999). Serotonin 5-HT2G receptor RNA editing alters receptor basal activity: Implications for serotonergic signal transduction. J. Neurochem. 73, 1711-1717.
183. Hesselink, J. M. K., and Sambunaris, A. (1995). Behavioral pharmacology of serotonin receptor subtypes: Hypotheses for clinical applications of selective serotonin ligands. Int. Rev. Psychiatr. 7, 41-53.
184. Hietala, J., Koulu, M., Kuoppamaki, M., Lappalainen, J., and Syvalahti, E. (1992). Chronic clozapine treatment down-regulates serotonin 5-HT-1c receptors in rat brain. Prog. Neuropsychopharmacol. Biol. Psychiat. 16, 727-732.
185. Hillion, J., Milne-Edwards, J. B., Catelon, J., de Vitry, F., Gros, F., and Hamon, M. (1993). Prenatal developmental expression of rat brain 5-HT1A receptor gene followed by PCR. Biochem. Biophys. Res. Commun. 191, 991-997.
186. Hirst, W. D., Cheung, N. Y., Rattray, M., Price, G. W., and Wilkin, G. P. (1998). Cultured astrocytes express messenger RNA for multiple serotonin receptor subtypes, without functional coupling of 5-HT1 receptor subtypes to adenylyl cyclase. Brain Res. Mol. Brain Res. 61, 90-99.
187. Holden, R. J. (1995). Schizophrenia, suicide and the serotonin story. Med. Hypoth. 44, 379-391.
188. Hollander, E., Kaplan, A., Cartwright, C., and Reichman, D. (2000a). Venlafaxine in children, adolescents, and young adults with autism spectrum disorders: An open retrospective clinical report. J. Child Neurol. 15, 132-135.
189. Hollander, E., Novotny, S., Allen, A., Aronowitz, B., Cartwright, C., and DeCaria, C. (2000b). The relationship between repetitive behaviors and growth hormone response to sumatriptan challenge in adult autistic disorder. Neuropsychopharmacology. 22, 163-167.
190. Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., and Humphrey, P. P. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46, 157-203.
191. Huang, C. C., Hsu, K. S., and Gean, P. W. (1996). Isoproterenol potentiates synaptic transmission primarily by enhancing presynaptic calcium influx via P- and/or Q-type calcium channels in the rat amygdala. J. Neurosci. 16, 1026-1033.
192. Hubel, D. H., and Wiesel, T. N. (1970). The period of susceptibility to the physiological effects of unilateral eye closure in kittens. J. Physiol. 206, 419-436.
193. Huttenlocher, P. R., and Dabholkar, A. S. (1997). Regional differences in synaptogenesis in human cerebral cortex. J. Comp. Neurol. 387, 167-178.
194. Ike, J., Canton, H., and Sanders-Bush, E. (1995). Developmental switch in the hippocampal serotonin receptor linked to phosphoinositide hydrolysis. Brain Res. 678, 49-54.
195. Inayama, Y., Yoneda, H., Sakai, T., Ishida, T., Nonomura, Y., Kono, Y., Takahata, R., Koh, J., Sakai, J., Takai, A., Inada, Y., and Asaba, H. (1996). Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia. Am. J. Med. Genet. 67, 103-105.
196. Inoue, T., Hashimoto, S., Tsuchiya, K., Izumi, T., Ohmori, T., and Koyama, T. (1996). Effect of citalopram, a selective serotonin reuptake inhibitor, on the acquisition of conditioned freezing. Eur. J. Pharmacol. 311, 1-6.
197. Iwamoto, K., and Kato, T. (2003). RNA editing of serotonin 2C receptors in human postmortem brains of major mental disorders. Neurosci. Lett. 346, 169-172.
198. Jacobs, B. L., and Azmitia, E. G. (1992). Structure and function of the brain serotonin system. Physiol. Rev. 72, 165-229.
199. Jacobs, B. L., and Trulson, M. E. (1979). Mechanisms of action of LSD. Am. Sci. 67, 396-404.
200. Jallon, P., and Picard, F. (2001). Body weight gain and anticonvulsants: A comparative review. Drug Safety 24, 969-978.
201. Joffe, H., and Cohen, L. S. (1998). Estrogen, serotonin, and mood disturbance: Where is the therapeutic bridge? Biol. Psychiat. 44, 798-811.
202. John, N. J., Lew, G. M., Goya, L., and Timiras, P. S. (1991). Effects of serotonin on tyrosine hydroxylase and tau protein in a human neuroblastoma cell line. Adv. Exp. Med. Biol. 296, 69-80.
203. Jones, L. B. (2001). Recent cytoarchitechtonic changes in the prefrontal cortex of schizophrenics. Front. Biosci. 6, E148-E153.
204. Jones, P. (1994). Schizophrenia after prenatal exposure to the Dutch hunger winter of 1944-1945. Arch. Gen. Psychiat. 51, 333-334.
205. Jones, P., Rodgers, B., Murray, R., and Marmot, M. (1994). Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 344, 1398-1402.
206. Joyce, J. N., Shane, A., Lexow, N., Winokur, A., Casanova, M. F., and Kleinman, J. E. (1993). Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology 8, 315-336.
207. Julius, D., Huang, K. N., Livelli, T. J., Axel, R., and Jessell, T. M. (1990). The 5HT2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors. Proc. Natl. Acad. Sci. USA 87, 928-932.
208. Julius, D., Livelli, T. J., Jessell, T. M., and Axel, R. (1989). Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation. Science 244, 1057-1062.
209. Kandel, E. R., and O'Dell, T. J. (1992). Are adult learning mechanisms also used for development? Science 258, 243-245.
210. Kandel, E. R., and Spencer, W. A. (1968). Cellular neurophysiological approaches in the study of learning. Physiol. Rev. 48, 65-134.
211. Kapur, S., and Remington, G. (1996). Serotonin-dopamine interaction and its relevance to schizophrenia. Am. J. Psychiat. 153, 466-476.
212. Kato, K., Suzuki, F., Kurobe, N., Okajima, K., Ogasawara, N., Nagaya, M., and Yamanaka, T. (1990). Enhancement of S-100 beta protein in blood of patients with Down's syndrome. J. Mol. Neurosci. 2, 109-113.
213. Kato, S., Fujiwara, I., and Yoshida, N. (1999). Nitrogen-containing heteroalicycles with serotonin receptor binding affinity. Development of gastroprokinetic and antiemetic agents. Med. Res. Rev. 19, 25-73.
214. Kaye, W. H., Gwirtsman, H. E., George, D. T., and Ebert, M. H. (1991). Altered serotonin activity in anorexia nervosa after long-term weight restoration: Does elevated cerebrospinal fluid 5-hydroxyindoleacetic acid level correlate with rigid and obsessive behavior? Arch. Gen. Psychiat. 48, 556-562.
215. Kellar, K. J., Cascio, C. S., Butler, J. A., and Kurtzke, R. N. (1981). Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2 receptors in rat brain. Eur. J. Pharmacol. 69, 515-518.
216. Kendler, K. S., Bulik, C. M., Silberg, J., Hettema, J. M., Myers, J., and Prescott, G. A. (2000). Childhood sexual abuse and adult psychiatric and substance use disorders in women: An epidemiological and cotwin control analysis. Arch. Gen. Psychiat. 57, 953-959.
217. Kendler, K. S., Gardner, C. O., and Prescott, C. A. (2002a). Toward a comprehensive developmental model for major depression in women. Am. J. Psychiatr. 159, 1133-1145.
218. Kendler, K. S., Kessler, R. G., Neale, M. C., Heath, A. C., and Eaves, L. J. (1993). The prediction of major depression in women: Toward an integrated etiologic model. Am. J. Psychiat. 150, 1139-1148.
219. Kendler, K. S., Neale, M. C., Kessler, R. C., Heath, A. C., and Eaves, L. J. (1992). Childhood parental loss and adult psychopathology in women: A twin study perspective. Arch. Gen. Psychiat. 49, 109-116.
220. Kendler, K. S., Neale, M. C., Prescott, C. A., Kessler, R. C., Heath, A. C., Corey, L. A., and Eaves, L. J. (1996). Childhood parental loss and alcoholism in women: A causal analysis using a twin-family design. Psychol. Med. 26, 79-95.
221. Kendler, K. S., Sheth, K., Gardner, C. O., and Prescott, C. A. (2002b). Childhood parental loss and risk for first-onset of major depression and alcohol dependence: The time-decay of risk and sex differences. Psychol. Med. 32, 1187-1194.
222. Keshavan, M. S., Rosenberg, D., Sweeney, J. A., and Pettegrew, J. W. (1998). Decreased caudate volume in neuroleptic-naive psychotic patients. Am. J. Psychiat. 155, 774-778.
223. Kessler, R. C., Davis, C. G., and Kendler, K. S. (1997). Childhood adversity and adult psychiatric disorder in the US National Comorbidity Survey. Psychol. Med. 27, 1101-1119.
224. Kesterson, K. L., Lane, R. D., and Rhoades, R. W. (2002). Effects of elevated serotonin levels on patterns of GAP-43 expression during barrel development in rat somatosensory cortex. Brain Res. Dev. Brain Res. 139, 167-174.
225. Kientz, M. A., and Dunn, W. (1997). A comparison of the performance of children with and without autism on the sensory profile. Am. J. Occup. Ther. 51, 530-537.
226. Kim, C. K., Kalynchuk, L. E., Kornecook, T. J., Mumby, D. G., Dadgar, N. A., Pinel, J. P., and Weinberg, J. (1997). Object-recognition and spatial learning and memory in rats prenatally exposed to ethanol. Behav. Neurosci. III, 985-995.
227. Kim, C. S., McNamara, M. C., Lauder, J. M., and Lawson, E. E. (1994). Immunocytochemical detection of serotonin content in raphe neurons of newborn and young adult rabbits before and after acute hypoxia. Int. J. Dev. Neurosci. 12, 499-505.
228. Kimmel, S. E., Calabrese J. R., Woyshville, M. J., and Meltzer, H. Y. (1994). Clozapine in treatment-refractory mood disorders. J. Clin. Psychiat. 55(Suppl. B), 91-93.
229. Klancnik, J. M., Obenaus, A., Phillips, A. G., and Baimbridge, K. G. (1991). The effects of serotonergic compounds on evoked responses in the dentate gyrus and CA1 region of the hippocampal formation of the rat. Neuropharmacology 30, 1201-1209.
230. Koe, B. K., and Weissman, A. (1966). β-Chlorophenylalanine: A specific depletor of brain serotonin. J. Pharmacol. Exp. Ther. 154, 499-516.
231. Kojic, L., Dyck, R. H., Gu, Q., Douglas, R. M., Matsubara J., and Cynader, M. S. (2000). Columnar distribution of serotonin-dependent plasticity within kitten striate cortex. Proc. Natl. Acad. Sci. USA 97, 1841-1844.
232. Kojic, L., Gu, Q., Douglas, R. M., and Cynader, M. S. (1997). Serotonin facilitates synaptic plasticity in kitten visual cortex: An in vitro study. Brain Res. Dev. Brain Res. 101, 299-304.
233. Kojic, L., Gu, Q., Douglas, R. M., and Cynader, M. S. (2001). Laminar distribution of cholinergic- and serotonergic-dependent plasticity within kitten visual cortex. Brain Res. Dev. Brain Res. 126, 157-162.
234. Kojima, T., Homma, S., Sako, H., Shimizu, I., Okada, A., and Okado, N. (1988). Developmental changes in density and distribution of serotoninergic fibers in the chick spinal cord. J. Comp. Neurol. 267, 580-589.
235. Kolb, B. (1984). Functions of the frontal cortex of the rat: A comparative review. Brain Res. 320, 65-98.
236. Kontur, P. J., Leranth, G., Redmond, D. E., Jr., Roth, R. H., and Robbins, R. J. (1993). Tyrosine hydroxylase immunoreactivity and monoamine and metabolite levels in cryopreserved human fetal ventral mesencephalon. Exp. Neurol. 121, 172-180.
237. Koponen, H., Saari, K., Savolainen, M., and Isohanni, M. (2002). Weight gain and glucose and lipid metabolism disturbances during antipsychotic medication: A review. Eur. Arch. Psy. Clin. N. 252, 294-298.
238. Korte, S. M., Meijer, O. C., de Kloet, E. R., Buwalda, B., Keijser, J., Sluyter, F., van Oortmerssen, G., and Bonus, B. (1996). Enhanced 5-HT1A receptor expression in forebrain regions of aggressive house mice. Brain Res. 736, 338-343.
239. Kosofsky, B. E., and Molliver, M. E. (1987). The serotoninergic innervation of cerebral cortex: Different classes of axon terminals arise from dorsal and median raphe nuclei. Synapse 1, 153-168.
240. Kovacs, G. G., Kloppel, S., Fischer, I., Dorner, S., Lindeck-Pozza, E., Birner, P., Botefur, I. C., Pilz, P., Volk, B., and Budka, H. (2003). Nucleus-specific alteration of raphe neurons in human neurodegenerative disorders. Neuroreport 14, 73-76.
241. Krezel, W., Dupont, S., Krust, A., Chambon, P., and Chapman, P. F. (2001). Increased anxiety and synaptic plasticity in estrogen receptor beta-deficient mice. Proc. Natl. Acad. Sci. USA 98, 12278-12282.
242. Lafaille, F., Welner, S. A., and Suranyi-Cadotte, B. E. (1991). Regulation of serotonin type 2 (5-HT2) and beta-adrenergic receptors in rat cerebral cortex following novel and classical antidepressant treatment. J. Psychiat. Neurosci. 16, 209-214.
243. Lambert, H. W., and Lauder, J. M. (1999). Serotonin receptor agonists that increase cyclic AMP positively regulate IGF-I in mouse mandibular mesenchymal cells. Dev. Neurosci. 21, 105-112.
244. Lapiz, M. D., Fulford, A., Muchimapura, S., Mason, R., Parker, T., and Marsden, C. A. (2001). Influence of postweaning social isolation in the rat on brain development, conditioned behaviour and neurotransmission. Ross Fiziol Zh Im I M Sechenova. 87, 730-751.
245. Lamelle, M., Abi-Dargham, A., Casanova, M. F., Toti, R., Weinberger, D. R., and Kleinman, J. E. (1993). Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study. Arch. Gen. Psychiat. 50, 810-818.
246. Lauder, J. M. (1990). Ontogeny of the serotonergic system in the rat: Serotonin as a developmental signal. Ann. N. Y. Acad. Sci. 600, 297-313; discussion 314.
247. Lauder, J. M., and Krebs, H. (1976). Effects of p-chlorophenylalanine on time of neuronal origin during embryogenesis in the rat. Brain Res. 107, 638-644.
248. Lauder, J. M., and Krebs, H. (1978). Serotonin as a differentiation signal in early neurogenesis. Dev. Neurosci. 1, 15-30.
249. Lauder, J. M., Liu, J., and Grayson, D. R. (2000). In utero exposure to serotonergic drugs alters neonatal expression of 5-HT(1A) receptor transcripts: A quantitative RT-PCR study. Int. J. Dev. Neurosci. 18, 171-176.
250. Lauder, J. M., Towle, A. C., Patrick, K., Henderson, P., and Krebs, H. (1985). Decreased serotonin content of embryonic raphe neurons following maternal administration of p-chlorophenylalanine: A quantitative immunocytochemical study. Brain Res. 352, 107-114.
251. Lauder, J. M., Wallace, J. A., and Krebs, H. (1981). Roles for serotonin in neuroembryogenesis. Adv. Exp. Med. Biol. 133, 477-506.
252. Lawrie, S. M., and Abukmeil, S. S. (1998). Brain abnormality in schizophrenia: A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br. J. Psychiat. 172, 110-120.
253. Lebrand, C., Cases, O., Adelbrecht, C., Doye, A., Alvarez, C., El Mestikawy, S., Seif, I., and Gaspar, P. (1996). Transient uptake and storage of serotonin in developing thalamic neurons. Neuron 17, 823-835.
254. Lee, S. L., Wang, W. W., and Fanburg, B. L. (1997). Association of Tyr phosphorylation of GTPase-activating protein with mitogenic action of serotonin. Am. J. Physiol. 272, C223-C230.
255. Leranth, C., Shanabrough, M., and Horvath, T. L. (2000). Hormonal regulation of hippocampal spine synapse density involves subcortical mediation. Neuroscience 101, 349-356.
256. Lerer, B., Macciardi, F., Segman, R. H., Adolfsson, R., Blackwood, D., Blairy, S., Del Favero, J., Dikeos, D. G., Kaneva, R., Lilli, R., Massat, I., Milanova, V., Muir, W., Noethen, M., Oruc, L., Petrova, T., Papadimitriou, G. N., Rietschel, M., Serretti, A., Souery, D., Van Gestel, S., Van Broeckhoven, C., and Mendlewicz, J. (2001). Variability of 5-HT2G receptor cys23ser polymorphism among European populations and vulnerability to affective disorder. Mol. Psychiat. 6, 579-585.
257. Leslie, M. J., Bennett-Clarke, C. A., and Rhoades, R. W. (1992). Serotonin 1B receptors form a transient vibrissa-related pattern in the primary somatosensory cortex of the developing rat. Brain Res. Dev. Brain Res. 69, 143-148.
258. Levallois, C., Valence, C., Baldet, P., and Privat, A. (1997). Morphological and morphometric analysis of serotonin-containing neurons in primary dissociated cultures of human rhombencephalon: A study of development. Brain Res. Dev. Brain Res. 99, 243-252.
259. Leven, R. M., Gonnella, P. A., Reeber, M. J., and Nachmias, V. T. (1983). Platelet shape change and cytoskeletal assembly: Effects of pH and monovalent cation ionophores. Thromb. Haemost. 49, 230-234.
260. Lewis, D. A., and Levitt, P. (2002). Schizophrenia as a disorder of neurodevelopment. Annu. Rev. Neurosci. 25, 409-432.
261. Lidov, H. G., and Molliver, M. E. (1982). Immunohistochemical study of the development of serotonergic neurons in the rat CNS. Brain Res. Bull. 9, 559-604.
262. Lidow, M. S., and Rakic, P. (1992). Scheduling of monoaminergic neurotransmitter receptor expression in the primate neocortex during postnatal development. Cereb. Cortex 2, 401-416.
263. Lopez, J. F., Chalmers, D. T., Little, K. Y., and Watson, S. J. (1998). A. E. Bennett Research Award. Regulation of serotonin 1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: Implications for the neurobiology of depression. Biol. Psychiat. 43, 547-573.
264. Lopez, J. F., Liberzon, I., Vazquez, D. M., Young, E. A., and Watson, S. J. (1999). Serotonin 1A receptor messenger RNA regulation in the hippocampus after acute stress. Biol. Psychiat. 45, 934-937.
265. Lunardi, G., Mainardi, P., Rubino, V., Fracassi, M., Favale, E., and Albano, C. (1995). Serotonin and epilepsy. Epilepsia 36, S165.
266. Luque, C. A., and Rey, J. A. (1999). Sibutramine: A serotonin- norepinephrine reuptake inhibitor for the treatment of obesity. Ann. Pharmacother. 33, 968-978.
267. Manjarrez, G. G., Magdaleno, V. M., Chagoya, G., and Hernandez, J. (1996). Nutritional recovery does not reverse the activation of brain serotonin synthesis in the ontogenetically malnourished rat. Int. J. Dev. Neurosci. 14, 641-648.
268. Mann, D. M., Yates, P. O., Marcyniuk, B., and Ravindra, C. R. (1985). Pathological evidence for neurotransmitter deficits in Down's syndrome of middle age. J. Ment. Defic. Res. 29(Pt.2), 125-135.
269. Mann, J. J., McBride, P. A., and Stanley, M. (1986a). Postmortem monoamine receptor and enzyme studies in suicide. Ann. N. Y. Acad. Sci. 487, 114-121.
270. Mann, J. J., McBride, P. A., and Stanley, M. (1986b). Postmortem serotonergic and adrenergic receptor binding to frontal cortex: Correlations with suicide. Psychopharmacol. Bull. 22, 647-649.
271. Mann, J. J., Stanley, M., McBride, P. A., and McEwen, B. S. (1986c). Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Arch. Gen. Psychiat. 43, 954-959.
272. Marazziti, D., Muratori, F., Cesari, A., Masala, I., Baroni, S., Giannaccini, G., Dell'Osso, L., Cosenza, A., Pfanner, P., and Cassano, G. B. (2000). Increased density of the platelet serotonin transporter in autism. Pharmacopsychiatry 33, 165-168.
273. Marek, G. J., Li, A. A., and Seiden, L. S. (1989). Selective 5-hydroxytryptamine2 antagonists have antidepressant-like effects on differential-reinforcement-of-low-rate 72-second schedule. J. Pharmacol. Exp. Ther. 250, 52-59.
274. Maren, S., Aharonov, G., and Fanselow, M. S. (1997). Neurotoxic lesions of the dorsal hippocampus and Pavlovian fear conditioning in rats. Behav. Brain Res. 88, 261-274.
275. Marenco, S., and Weinberger, D. R. (2000). The neurodevelopmental hypothesis of schizophrenia: Following a trail of evidence from cradle to grave. Dev. Psychopathol. 12, 501-527.
276. Martin, S. J., Grimwood, P. D., and Morris, R. G. (2000). Synaptic plasticity and memory: An evaluation of the hypothesis. Annu. Rev. Neurosci. 23, 649-711.
277. Masellis, M., Basile, V., Meltzer, H. Y., Lieberman, J. A., Sevy, S., Macciardi, F. M., Cola, P., Howard, A., Badri, F., Northen, M. M., Kalow, W., and Kennedy, J. L. (1998). Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients. Neuropsychopharmacology 19, 123-132.
278. Masellis, M., Paterson, A. D., Badri, F., Lieberman, J. A., Meltzer, H. Y., Cavazzoni, P., and Kennedy, J. L. (1995). Genetic variation of 5-HT2A receptor and response to clozapine. Lancet 346, 1108.
279. Matilla, A., Roberson, E. D., Banfi, S., Morales, J., Armstrong, D. L., Burright, E. N., Orr, H. T., Sweatt, J. D., Zoghbi, H. Y., and Matzuk, M. M. (1998). Mice lacking ataxin-1 display learning deficits and decreased hippocampal paired-pulse facilitation. J. Neurosci. 18, 5508-5516.
280. Matsukawa, M., Ogawa, M., Nakadate, K., Macshima, T., Ichitani, Y., Kawai, N., and Okado, N. (1997). Serotonin and acetylcholine are crucial to maintain hippocampal synapses and memory acquisition in rats. Neurosci. Lett. 230, 13-16.
281. Mayford, M., and Kandel, E. R. (1999). Genetic approaches to memory storage. Trends Genet. 15, 463-470.
282. Mazer, C., Muneyyirci, J., Taheny, K., Raio, N., Borella, A., and Whitaker-Azmitia, P. (1997). Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: A possible model of neurodevelopmental disorders with cognitive deficits. Brain Res. 760, 68-73.
283. McDougle, G. J., Kresch, L. E., and Posey, D. J. (2000). Repetitive thoughts and behavior in pervasive developmental disorders: Treatment with serotonin reuptake inhibitors. J. Autism Dev. Disord. 30, 427-435.
284. McDougle, C. J., Naylor, S. T., Goodman, W. K., Volkmar, F. R., Cohen, D. J., and Price, L. H. (1993). Acute tryptophan depletion in autistic disorder: A controlled case study. Biol. Psychiat. 33, 547-550.
285. McGlashan, T. H., and Hodman, R. E. (2000). Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch. Gen. Psychiat. 57, 637-648.
286. McKeith, I. G., Marshall, E. F., Ferner, I. N., Armstrong, M. M., Kennedy, W. N., Perry, R. H., Perry, E. K., and Eccleston, D. (1987). 5-HT receptor binding in post-mortem brain from patients with affective disorder. J. Affect. Disord. 13, 67-74.
287. McKittrick, C. R., Blanchard, D. C., Blanchard, R. J., McEwen, B. S., and Sakai, R. R. (1995). Serotonin receptor binding in a colony model of chronic social stress. Biol. Psychiat. 37, 383-393.
288. McNeely, W., and Goa, K. L. (1998). Sibutramine: A review of its contribution to the management of obesity. Drugs 56, 1093-1124.
289. Meaney, M. J., Diorio, J., Francis, D., LaRocque, S., O'Donnell, D., Smythe, J. W., Sharma, S., and Tannenbaum, B. (1994). Environmental regulation of the development of glucocorticoid receptor systems in the rat forebrain: The role of serotonin. Ann. N. Y. Acad. Sci. 746, 260-273; discussion 274, 289-293.
290. Meert, T. F., Metis, W., Aerts, N., and Clincke, G. (1997). Antagonism of meta-chlorophenylpiperazine-induced inhibition of exploratory activity in an emergence procedure, the open field test, in rats. Behav. Pharmacol. 8, 353-363.
291. Meijer, O. C., Cole, T. J., Schmid, W., Schutz, G., Joels, M., and De Kloet, E. R. (1997). Regulation of hippocampal 5-HT1A receptor mRNA and binding in transgenic mice with a targeted disruption of the glucocorticoid receptor. Brain Res. Mol. Brain Res. 46, 290-296.
292. Meijer, O. C., Van Oosten, R. V., and De Kloet, E. R. (1997). Elevated basal trough levels of corticosterone suppress hippocampal 5- hydroxytryptamine(1A) receptor expression in adrenally intact rats: Implication for the pathogenesis of depression. Neuroscience 80, 419-426.
293. Meltzer, H. Y. (2002). Commentary on "Clinical studies on the mechanism of action of clozapine; the dopamine-serotonin hypothesis of schizophrenia." Psychopharmacology 163, 1-3.
294. Meltzer, H. Y., Bastani, B., Ramirez, L., and Matsubara, S. (1989a). Clozapine: New research on efficacy and mechanism of action. Eur. Arch. Psychiat. Neurol. Sci. 238, 332-339.
295. Meltzer, H. Y., Matsubara, S., and Lee, J. C. (1989b). Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J. Pharmacol. Exp. Ther. 251, 238-246.
296. Meltzer, H. Y., Matsubara, S., and Lee, J. C. (1989c). The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs. Psychopharmacol. Bull. 25, 390-392.
297. Menard, J., and Treit, D. (1999). Effects of centrally administered anxiolytic compounds in animal models of anxiety. Neurosci. Biobehav. Rev. 23, 591-613.
298. Meredith, G. E., De Souza, I. E., Hyde, T. M., Tipper, G., Wong, M. L., and Egan, M. F. (2000). Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic-induced dyskinesias. J. Neurosci. 20, 7798-7806.
299. Merzak, A., Koochekpour, S., Fillion, M. P., Fillion, G., and Pilkington, G. J. (1996). Expression of serotonin receptors in human fetal astrocytes and glioma cell lines: A possible role in glioma cell proliferation and migration. Brain Res. Mol. Brain Res. 41, 1-7.
300. Micheva, K. D., and Beaulieu, C. (1996). Quantitative aspects of synaptogenesis in the rat barrel field cortex with special reference to GABA circuitry. J. Comp. Neurol. 373, 340-354.
301. Mikuni, M., Kagaya, A., Takahashi, K., and Meltzer, H. Y. (1992). Serotonin but not norepinephrine-induced calcium mobilization of platelets is enhanced in affective disorders. Psychopharmacology (Berl.) 106, 311-314.
302. Miller, J. H., and Azmitia, E. C. (1999). Growth inhibitory effects of a mu opioid on cultured cholinergic neurons from fetal rat ventral forebrain, brainstem, and spinal cord. Brain Res. Dev. Brain Res. 114, 69-77.
303. Miyata, M., Ito, M., Sasajima, T., Ohira, H., Sato, Y., and Kasukawa, R. (2000). Development of monocrotaline-induced pulmonary hypertension is attenuated by a serotonin receptor antagonist. Lung 178, 63-73.
304. Moiseiwitsch, J. R., and Lauder, J. M. (1995). Serotonin regulates mouse cranial neural crest migration. Proc. Natl. Acad. Sci. USA 92, 7182-7186.
305. Moiseiwitsch, J. R., and Lauder, J. M. (1997). Regulation of gene expression in cultured embryonic mouse mandibular mesenchyme by serotonin antagonists. Anat. Embryol. (Berl.) 195, 71-78.
306. Moiseiwitsch, J. R., Raymond, J. R., Tamir, H., and Lauder, J. M. (1998). Regulation by serotonin of tooth-germ morphogenesis and gene expression in mouse mandibular explant cultures. Arch. Oral Biol. 43, 789-800.
307. Mokler, D. J., Bronzino, J. D., Galler, J. R., and Morgane, P. J. (1999). The effects of median raphe electrical stimulation on serotonin release in the dorsal hippocampal formation of prenatally protein malnourished rats. Brain Res. 838, 95-103.
308. Monaco, F., Torta, R., Borio, R., Cicolin, A., and Ravizza, L. (1995). Epilepsy, depression, and the selective serotonin reuptake inhibitor drugs. Epilepsia 36, S175.
309. Muncoka, K., Ogawa, T., Kamei, K., Muraoka, S., Tomiyoshi, R., Mimura, Y., Kato, H., Suzuki, M. R., and Takigawa, M. (1997). Prenatal nicotine exposure affects the development of the central serotonergic system as well as the dopaminergic system in rat offspring: Involvement of route of drug administrations. Brain Res. Dev. Brain Res. 102, 117-126.
310. Murray, R. M., O'Callaghan, E., Castle, D. J., and Lewis, S. W. (1992). A neurodevelopmental approach to the classification of schizophrenia. Schizophr. Bull. 18, 319-332.
311. Namerow, L. B., Thomas, P., Bostic, J. Q., Prince, J., and Monuteaux, M. C. (2003). Use of citalopram in pervasive developmental disorders. J. Dev. Behav. Pediatr. 24, 104-108.
312. Nanson, J. L. (1992). Autism in fetal alcohol syndrome: A report of six cases. Alcohol Clin. Exp. Res. 16, 558-565.
313. Nebigil, C. G., Choi, D. S., Dierich, A., Hickel, P., Le Meur, M., Messaddeq, N., Launay, J. M., and Maroteaux, L. (2000). Serotonin 2B receptor is required for heart development. Proc. Natl Acad. Sci. USA 97, 9508-9513.
314. Nelson, D. R., Thomas, D. R., and Johnson, A. M. (1989). Pharmacological effects of paroxetine after repeated administration to animals. Acta Psychiatr. Scand. Suppl. 350, 21-23.
315. Nichols, C. D., Garcia, E. E., and Sanders-Bush, E. (2003). Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration. Brain Res. Mol. Brain Res. 111, 182-188.
316. Nichols, C. D., and Sanders-Bush, E. (2002). A single dose of lysergic acid diethylamide influences gene expression patterns within the mammalian brain. Neuropsychopharmacology 26, 634-642.
317. Niswender, C. M., Copeland, S. G., Herrick-Davis, K., Emeson, R. B., and Sanders-Bush, E. (1999). RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J. Biol. Chem. 274, 9472-9478.
318. Niswender, C. M., Herrick-Davis, K. et al. (2001). RNA editing of the human serotonin 5-HT2C receptor alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology. 24, 478-191.
319. Norrholm, S. D., and Ouimet, G. C. (2001). Altered dendritic spine density in animal models of depression and in response to antidepressant treatment. Synapse 42, 151-163.
320. Ohashi, S., Matsumoto, M., Otani, H., Mon, K., Togashi, H., Ueno, K., Kaku, A., and Yoshioka, M. (2002). Changes in synaptic plasticity in the rat hippocampo-medial prefrontal cortex pathway induced by repeated treatments with fluvoxamine. Brain Res. 949, 131-138.
321. Ohuoha, D. C., Hyde, T. M., and Kleinman, J. E. (1993). The role of serotonin in schizophrenia: An overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system. Psychopharmacology (Berl.) 112, S5-15.
322. Okado, N., Cheng, L., Tanatsugu, Y., Hamada, S., and Hamaguchi, K. (1993). Synaptic loss following removal of serotoninergic fibers in newly hatched and adult chickens. J. Neurobiol. 24, 687-698.
323. Okado, N., Narita, M., and Narita, N. (2001). A biogenic amine-synapse mechanism for mental retardation and developmental disabilities. Brain Dev. 23(Suppl. 1), S11-15.
324. Olivier, B., Pattij, T., Wood, S. J., Oosting, R., Sarnyai, Z., and Toth, M. (2001). The 5-HT(1A) receptor knockout mouse and anxiety. Behav. Pharmacol. 12, 439-450.
325. O'Steen, W. K., Barnard, J. L., Jr., and Yates, R. D. (1967). Morphologic changes in skeletal muscle induced by serotonin treatment: A light- and electron-microscope study. Exp. Mol. Pathol. 7, 145-155.
326. Osterheld-Haas, M. C., Van der Loos, H., and Hornung, J. P. (1994). Monoaminergic afferents to cortex modulate structural plasticity in the barrelfield of the mouse. Brain Res. Dev. Brain Res. 77, 189-202.
327. Pakkenberg, B. (1993). Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors. Biol. Psychiat. 34, 768-772.
328. Pakkenberg, B., and Gundersen, H. J. (1989). New stereological method for obtaining unbiased and efficient estimates of total nerve cell number in human brain areas: Exemplified by the mediodorsal thalamic nucleus in schizophrenics. Apmis 97, 677-681.
329. Palmer, B. W., McClure, F. S., and Jeste, D. V. (2001). Schizophrenia in late life: Findings challenge traditional concepts. Harv. Rev. Psychiat. 9, 51-58.
330. Pandey, G. N. (1997). Altered serotonin function in suicide: Evidence from platelet and neuroendocrine studies. Ann. N. Y. Acad. Sci. 836, 182-200.
331. Pandey, G. N., Pandey, S. C., Dwivedi, Y., Sharma, R. P., Janicak, P. G., and Davis, J. M. (1995). Platelet serotonin-2A receptors: A potential biological marker for suicidal behavior. Am. J. Psychiat. 152, 850-855.
332. Pare, W. P., and Tejani-Butt, S. M. (1996). Effect of stress on the behavior and 5-HT system in Sprague-Dawley and Wistar Kyoto rat strains. Integr. Physiol. Behav. Sci. 31, 112-121.
333. Parks, C. L., Robinson, P. S., Sibille, E., Shenk, T., and Toth, M. (1598). Increased anxiety of mice lacking the serotonin1A receptor. Proc. Natl. Acad. Sci. USA 95, 10734-10739.
334. Pazos, A., Hoyer, D., and Palacios, J. M. (1984). The binding of serotonergic ligands to the porcine choroid plexus: Characterization of a new type of serotonin recognition site. Eur. J. Pharmacol. 106, 539-546.
335. 3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain. J. Neurochem. 36, 220-226.
336. Pei, Q., Lewis, L., Sprakes, M. E. Jones, E. J., Grahame-Smith, D. G., and Zetterstrom, T. S. (2000). Serotonergic regulation of mRNA expression of Arc, an immediate early gene selectively localized at neuronal dendrites. Neuropharmacology 39, 463-470.
337. Peroutka, S. J., and Snyder, S. H. (1980). Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 210, 88-90.
338. 2+ channels. Brain Res. Brain Res. Rev. 40, 223-229.
339. Persico, A. M., Altamura, G., Calia, E., Puglisi-Allegra, S., Ventura, R., Lucchese, F., and Keller, F. (2000). Serotonin depletion and barrel cortex development: Impact of growth impairment vs. serotonin effects on thalamocortical endings. Cereb. Cortex 10, 181-191.
340. Persico, A. M., Mengual, E., Moessner, R., Hall, F. S., Revay, R. S., Sora, I., Arellano, J., DeFelipe, J., Gimenez-Amaya, J. M., Conciatori, M., Marino, R., Baldi, A., Cabib, S., Pascucci, T., Uhl, G. R., Murphy, D. L., Lesch, K. P., Keller, F., and Hall, S. F. (2001). Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release. J. Neurosci. 21, 6862-6873.
341. Peters, D. A. (1988). Both prenatal and postnatal factors contribute to the effects of maternal stress on offspring behavior and central 5-hydroxytryptamine receptors in the rat. Pharmacol. Biochem. Behav. 30, 669-673.
342. Pflieger, J. F., Clarac, F., and Vinay, L. (2002). Postural modifications and neuronal excitability changes induced by a short-term serotonin depletion during neonatal development in the rat. J. Neurosci. 22, 5108-5117.
343. Pieri, L., Keller, H. H., Burkard, W., and Da Prada, M. (1978). Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis. Nature 272, 278-280.
344. Pilowsky, L. S., Kerwin, R. W., and Murray, R. M. (1993). Schizophrenia: A neurodevelopmental perspective. Neuropsychopharmacology 9, 83-91.
345. Pletnikov, M. V., Rubin, S. S., Schwartz, G. J., Carbone, K. M., and Moran, T. H. (2000). Effects of neonatal rat Borna disease virus (BDV) infection on the postnatal development of the brain monoaminergic systems. Brain Res. Dev. Brain Res. 119, 179-185.
346. Popenenkova, Z. A., Zuev, V. A., Romanovskaia, M. G., and Maslennikov, G. A. (1977). Acute and latent influenzal infection in mice with altered endogenous serotonin metabolism. Vopr Virusol 432-437.
347. Popken, G. J., Bunney, W. E., Jr., Potkin, S. G., and Jones, E. G. (2000). Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. Proc. Natl. Acad. Sci. USA 97, 9276-9280.
348. Posey, D. J., and McDougle, C. J. (2000). The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders. Harv. Rev. Psychiat. 8, 45-63.
349. Prasad, C. (1998). Food, mood and health: A neurobiologic outlook. Braz. J. Med. Biol. Res. 31, 1517-1527.
350. Radulovic J., Ruhmann, A., Liepold, T., and Spiess, J. (1999). Modulation of learning and anxiety by corticotropin-releasing factor (CRP) and stress: Differential roles of CRF receptors 1 and 2. J. Neurosci. 19, 5016-5025.
351. Rakic, P., and Goldman-Rakic, P. S. (1982). The development and modifiability of the cerebral cortex: Overview. Neurosci. Res. Program Bull. 20, 433-438.
352. Ramos, A. J., Tagliaferro, P., Lopez-Costa, J. J., Lopez, E. M., Pecci Saavedra, J., and Brusco, A. (2002). Neuronal and inducible nitric oxide synthase immunoreactivity following serotonin depletion. Brain Res. 958, 112-121.
353. Rapport, M. M., Green, A. A., and Page, I. H. (1948). Partial purification of the vasoconstrictor in beef serum. J. Biol. Chem. 174, 735-738.
354. Raymond, G. V., Bauman, M. L., and Kemper, T. L. (1996). Hippocampus in autism: A Golgi analysis. Acta Neuropathol. (Berl.) 91, 117-119.
355. Read, J., Perry, B. D., Moskowitz, A., and Connolly, J. (2001). The contribution of early traumatic events to schizophrenia in some patients: A traumagenic neurodevelopmental model. Psychiatry 64, 319-345.
356. Remmers, J. E. (1990). Sleeping and breathing. Chest 97, 77S-80S.
357. Rhoades, R. W., Mooney, R. D., Chiaia, N. L., and Bennett-Clarke, C. A. (1990). Development and plasticity of the serotoninergic projection to the hamster's superior colliculus. J. Comp. Neurol. 299, 151-166.
358. Rioux, A., Fabre, V., Lesch, K. P., Moessner, R., Murphy, D. L., Lanfumey, L., Hamon, M., and Martres, M. P. (1999). Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporter. Neurosci. Lett. 262, 113-116.
359. Ritvo, E. R., Yuwiler, A., Geller, E., Ornitz, E. M., Saeger, K., and Plotkin, S. (1970). Increased blood serotonin and platelets in early infantile autism. Arch. Gen. Psychiat. 23, 566-572.
360. Robinson, T. E., and Becker, J. B. (1986). Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Res. 396, 157-198.
361. Rogan, M. T., and LeDoux, J. E. (1996). Emotion: Systems, cells, synaptic plasticity. Cell 85, 469-175.
362. Roskams, A. J., Bredt, D. S., Dawson, T. M., and Ronnett, G. V. (1994). Nitric oxide mediates the formation of synaptic connections in developing and regenerating olfactory receptor neurons. Neuron 13, 289-299.
363. Rosoklija, G., Toomayan, G., Ellis, S. P., Keilp, J., Mann, J. J., Latov, N., Hays, A. P., and Dwork, A. J. (2000). Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: Preliminary findings. Arch. Gen. Psychia. 57, 349-356.
364. Rothman, R. B., and Baumann, M. H. (2002). Serotonin releasing agents: Neurochemical therapeutic and adverse effects. Pharmacol. Biochem. Be 71, 825-836.
365. Rubenstein, J. L. (1998). Development of serotonergic neurons and their projections. Biol. Psychiat. 44, 145-150.
366. Sanders-Bush, E., and Breeding, M. (1991). Choroid plexus epithelial cells in primary culture: A model of 5HT1C receptor activation by hallucinogenic drugs. Psychopharmacology (Berl.) 105, 340-346.
367. Sanders-Bush, E., Burris, K. D., and Knoth, K. (1988). Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. J. Pharmacol. Exp. Ther. 246, 924-928.
368. Sanders-Bush, E., Bushing, J. A., and Sulser, F. (1972a). Long-term effects of p-chloroamphetamine on tryptophan hydroxylase activity and on the levels of 5-hydroxytryptamine and 5-hydroxyindole acetic acid in brain. Ear. J. Pharmacol. 20, 385-388.
369. Sanders-Bush, E., Bushing, J. A., and Sulser, F. (1972b). p-Chloroamphetamine: Inhibition of cerebral tryptophan hydroxylase. Biochem. Pharmacol. 21, 1501-1510.
370. Sanders-Bush, E., and Conn, P. J. (1986). Effector systems coupled to serotonin receptors in brain: Serotonin stimulated phosphoinositide hydrolysis. Pychopharmacol. Bull. 22, 829-836.
371. Sanders-Bush, E., Gallager, D. A., and Sulser, F. (1974). On the mechanism of brain 5-hydroxytryptamine depletion by p-chloroamphetamine and related drugs and the specificity of their action. Adv. Biochem. Pychopharmacol. 10, 185-194.
372. Sargent, P. A., Kjaer, K. H., Bench, C. J., Rabiner, E. A., Messa, C., Meyer J., Gunn, R. N., Grasby, P. M., and Cowen, P. J. (2000). Brain serotonin IA receptor binding measured by positron emission tomography with [11G]WAY-100635: Effects of depression and antidepressant treatment. Arch. Gen. Pychiat. 57, 174-180.
373. Sari, Y., Powrozek, T., and Zhou, F. C. (2001). Alcohol deters the outgrowth of serotonergic neurons at midgestation. J. Biomed. Sci. 8, 119-125.
374. Sarihi, A., Fathollahi, Y., Motamedi, F., Naghdi, N., and Rashidy-Pour, A. (2003). Effects of lidocaine reversible inactivation of the median raphe nucleus on long-term potentiation and recurrent inhibition in the dentate gyrus of rat hippocampus. Brain Res. 962, 159-168.
375. Sarihi, A., Motamedi, F., Naghdi, N., and Rashidy-Pour, A. (2000). Lidocaine reversible inactivation of the median raphe nucleus has no effect on reference memory but enhances working memory versions of the Morris water maze task. Behav. Brain Res. 114, 1-9.
376. Sarihi, A., Motamedi, F., Rashidy-Pour, A., Naghdi, N., and Behzadi, G. (1999). Reversible inactivation of the median raphe nucleus enhances consolidation and retrieval but not acquisition of passive avoidance learning in rats. Brain Res. 817, 59-66.
377. Sarnyai, Z., Sibille, E. L., Pavlides, C., Fenster, R. J., McEwen, B. S., and Toth, M. (2000). Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors. Proc. Natl. Acad. Sci. USA 97, 14731-14736.
378. Satoh, J., Gallyas, F., Jr., Endoh, M., Yamamura, T., Kunishita, T., Kobayashi, T., and Tabira, T. (1992). Establishment of mouse-immortalized hybrid clones expressing characteristics of differentiated neurons derived from the cerebellar and brain stem regions. J. Neurobiol. 23, 905-919.
379. Savic, I., Gulyas, B., Lindstrom, P., Halldin, C., and Farde, L. (2001). Mesial temporal lobe epilepsy is associated with limbic reductions in serotonin 5HT1A receptor binding. Neuroimage 13, S833.
380. Schildkraut, J. J. (1965). The catecholamine hypothesis of affective disorders: A review of supporting evidence. Am. J. Pychiat. 122, 509-522.
381. Scott, B. S., Becker, L. E., and Petit, T. L. (1983). Neurobiology of Down's syndrome. Prog. Neurobiol. 21, 199-237.
382. Seidl, R., Kaehler, S. T., Prast, H., Singewald, N., Cairns, N., Gratzer, M., and Lubec, G. (1999). Serotonin (5-HT) in brains of adult patients with Down syndrome. J. Neural Transm. Suppl. 57, 221-232.
383. Selemon, L. D., and Goldman-Rakic, P. S. (1999). The reduced neuropil hypothesis: A circuit based model of schizophrenia. Biol. Pychiat. 45, 17-25.
384. Selemon, L. D., Rajkowska, G., and Goldman-Rakic, P. S. (1995). Abnormally high neuronal density in the schizophrenic cortex: A morphometric analysis of prefrontal area 9 and occipital area 17. Arch. Gen. Pychiat. 52, 805-818; discussion 819-820.
385. Selemon, L. D., Rajkowska, G., and Goldman-Rakic, P. S. (1998). Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: Application of a three-dimensional, stereologic counting method. J. Comp. Neurol. 392, 402-412.
386. Shen, W. Z., Luo, Z. B., Zheng, D. R., and Yew, D. T. (1989). Immunohistochemical studies on the development of 5-HT (serotonin) neurons in the nuclei of the reticular formations of human fetuses. Pediatr. Neurosci. 15, 291-295.
387. Shuey, D. L., Sadler, T. W., and Lauder, J. M. (1992). Serotonin as a regulator of craniofacial morphogenesis: Site specific malformations following exposure to serotonin uptake inhibitors. Teratology 46, 367-378.
388. Shuey, D. L., Sadler, T. W., Tamir, H., and Lauder, J. M. (1993). Serotonin and morphogenesis: Transient expression of serotonin uptake and binding protein during craniofacial morphogenesis in the mouse. Anal. Embyol. (Bal.) 187, 75-85.
389. Shutoh, K, Hamada, S., Shibata, M., Narita, M., Shiga, T., Azmitia, E. C., and Okado, N. (2000). Long term depletion of serotonin leads to selective changes in glutamate receptor subunits. Neurosci. Res. 38, 365-371.
390. Sibille, E., Pavlides, C., Benke, D., and Toth, M. (2000). Genetic inactivation of the Serotonin(1A) receptor in mice results in downregulation of major GABA(A) receptor alpha subunits, reduction of GABA(A) receptor binding, and benzodiazepine-resistant anxiety. J. Neurosci. 20, 2758-2765.
391. Silva, A. J. (2003). Molecular and cellular cognitive studies of the role of synaptic plasticity in memory. J. Neurobiol. 54, 224-237.
392. 3H]8-OH-DPAT reveals increases in 5-HT(1A) receptors in ventral prefrontal cortex in schizophrenia. Biol. Pychiat. 39, 919-928.
393. Slade, P. D. (1976). An investigation of psychological factors involved in the predisposition to auditory hallucinations. Pychol. Med. 6, 123-132.
394. Smith, K. A., Fairbum, C. G., and Cowen, P. J. (1997). Relapse of depression after rapid depletion of tryptophan. Lancet 349, 915-919.
395. Soares, C. N., Almeida, O. P., Joffe, H., and Cohen, L. S. (2001). Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: A double-blind, randomized, placebo-controlled trial. Arch. Gen. Pychiat. 58, 529-534.
396. Soares, C. N., and Cohen, L. S. (2001). The perimenopause, depressive disorders, and hormonal variability. Sao Paulo Med. J. 119, 78-83.
397. Sodhi, M. S., Aitchison, K. J., Kerwin, R. W., and Sham, P. (1999). The role of the 5-HT2A receptor gene in psychosis. Am. J. Hum. Genet. 65, A469.
398. Sodhi, M. S., Arranz, M. J., Curds, D., Ball, D. M., Sham, P., Roberts, G. W., Price, J., Collier, D. A., and Kerwin, R. W. (1995). Association between clozapine response and allelic variation in the 5-HT2G receptor gene. Neuroreport 7, 169-172.
399. Sodhi, M. S., Burnet, P. W. J., Makoff, A. J., Kerwin, R. W., and Harrison, P. J. (2001). RNA editing of the 5-HT2C receptor is reduced in schizophrenia. Mol. Pychiat. 6, 373-379.
400. Sodhi, M. S., and Murray, R. M. (1997). Future therapies for schizophrenia. Expert. Opin. Ther. Pat. 7, 151-165.
401. Sodhi, M. S., Sham, P. C., Makoff, A. J., Collier, D. A., Arranz, M. J., Munro, J., and Kerwin, R. W. (1999b). Replication and meta-analysis of allelic association of a 5-HT2C receptor polymorphism with good response to clozapine. Mol. Pychiat. 4, S94-S95.
402. Southam, E., and Garthwaite, J. (1993). The nitric oxide-cyclic GMP signalling pathway in rat brain. Neuropharmacology 32, 1267-1277.
403. Spurlock, G., Heils, A., Holmans, P., Williams, J., D'Souza, U. M., Cardno, A., Murphy, K. C., Jones, L., Buckland, P. R., McGuffin, P., Lesch, K. P., and Owen, M. J. (1998). A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter. Mol. Pychiat. 3, 42-49.
404. Staner, L., Kempenaers, C., Simonnet, M. P., Fransolet, L., and Mendlewicz, J. (1992). 5-HT2 receptor antagonism and slow-wave sleep in major depression. Acta Pychiatr Scand 86, 133-137.
405. Stanley, M., Mann, J. J., and Cohen, L. S. (1986a). Role of the serotonergic system in the postmortem analysis of suicide. Pychophamacol. Bull. 22, 735-740.
406. Stanley, M., Mann, J. J., and Cohen, L. S. (1986b). Serotonin and serotonergic receptors in suicide. Am. N. Y. Acad. Sci. 487, 122-127.
407. Statnick, M. A., Dailey, J. W., Jobe, P. C., and Browning, R. A. (1996). Abnormalities in brain serotonin concentration, high-affinity uptake, and tryptophan hydroxylase activity in severe-seizure genetically epilepsy-prone rats. Epilepsia 37, 311-321.
408. Stiedl, O., Misane, I., Spiess, J., and Ogren, S. O. (2000). Involvement of the 5-HTIA receptors in classical fear conditioning in C57BL/6J mice. J. Neurosci. 20, 8515-8527.
409. Stober, G., Franzek, E., Haubitz, I., Pfuhlmann, B., and Beckmann, H. (1998). Gender differences and age of onset in the catatonic subtypes of schizophrenia. Pychopathology 31, 307-312.
410. Stockmeier, C. A., Dilley, G. E., Shapiro, L. A., Overholser, J. G., Thompson, P. A., and Meltzer, H. Y. (1997). Serotonin receptors in suicide victims with major depression. Neuropychophamacology. 16, 162-173.
411. 3H]-spiperone binding in rat frontal cortex and serotonin receptor mediated behaviour. Psychopharmacology (Berl.) 80, 150-155.
412. Stunkard, A. J., and Allison, K. C. (2003). Two forms of disordered eating in obesity: Binge eating and night eating. Int. J. Obesity 27, 1-12.
413. Sumiyoshi, T., Matsui, M., Yamashita, I., Nohara, S., Kurachi, M., Uehara, T., Sumiyoshi, S., Sumiyoshi, G., and Meltzer, H. Y. (2001). The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia. Biol. Pychiat. 49, 861-868.
414. Sumiyoshi, T., Stockmeier, C. A., Overholser, J. C., Dilley, G. E., and Meltzer, H. Y. (1996). Serotonin(1A) receptors are increased in postmortem prefrontal cortex in schizophrenia. Brain Res. 708, 209-214.
415. Sundstrom, E., Kolare, S., Souverbie, F., Samuelsson, E. B., Pschera, H., Lunell, N. O., and Seiger, A. (1993). Neurochemical differentiation of human bulbospinal monoaminergic neurons during the first trimester. Brain Res. Dev. Brain Res. 75, 1-12.
416. Szara, S. (1967). The hallucinogenic drugs: Curse or blessing? Am. J. Pychiat. 123, 1513-1518.
417. Tajuddin, N. F., and Druse, M. J. (1993). Treatment of pregnant alcohol-consuming rats with buspirone: effects on serotonin and 5-hydroxyindoleacetic acid content in offspring. Alcohol Clin. Exp. Res. 17, 110-114.
418. Takashima, S., Iida, K., Mito, T., and Arima, M. (1994). Dendritic and histochemical development and ageing in patients with Down's syndrome. J. Intellect. Disabil. Res. 38(Pt.3), 265-273.
419. Tecott, L. H., Sun, L. M., Akana, S. F., Strack, A. M., Lowenstein, D. H., Dallman, M. F., and Julius, D. (1995). Eating disorder and epilepsy in mice lacking 5-Ht2c serotonin receptors. Nature 374, 542-546.
420. Teyler, T. J., and Discenna, P. (1984). Long-term potentiation as a candidate mnemonic device. Brain Res. 319, 15-28.
421. Thorin, E., Capdeville, G., Trockle, G., Wernsperger, N., and Atkinson J. (1990). Chronic treatment with naftidrofuryl attenuates the development of vascular hypersensitivity to serotonin in the spontaneously hypertensive rat. J. Cardiovasc. Pharm. 16, S54-S57.
422. Titeler, M., Lyon, R. A., and Glennon, R. A. (1988). Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens. Pychopharmacology (Berl.) 94, 213-216.
423. Toth, G., and Fekete, M. (1986). 5-Hydroxyindole acetic excretion in newborns, infants and children. Acta Paediatr. Hung. 27, 221-226.
424. Treiser, S., and Kellar, K. J. (1980). Lithium: Effects on serotonin receptors in rat brain. Eur. J. Pharmacol. 64, 183-185.
425. Tu, J. B., and Zellweger, H. (1965). Blood-serotonin deficiency in Down's syndrome. Lancet 2, 715-716.
426. Turlejski, K. (1996). Evolutionary ancient roles of serotonin: Long-lasting regulation of activity and development. Acta Neurobiol. Exp. 56, 619-636.
427. Twarog, B. M., and Page, I. H. (1953). Serotonin content of some mammalian tissues and urine and a method for its determination. Am. J. Physiol. 175, 157-161.
428. Ueda, S., Aikawa, M., Kawata, M., Naruse, I., Whitaker-Azmitia, P. M., and Azmitia, E. C. (1996). Neuro-glial neurotrophic interaction in the S-100 beta retarded mutant mouse (Polydactyly Nagoya). III. Transplantation study. Brain Res. 738, 15-23.
429. Ueda, S., Gu, X. F., Whitaker-Azmitia, P. M., Naruse, I., and Azmitia, E. C. (1994a). Neuroglial neurotrophic interaction in the S-100 beta retarded mutant mouse (Polydactyly Nagoya). I. Immunocytochemical and neurochemical studies. Brain Res. 633, 275-283.
430. Ueda, S., Hou, X. P., Whitaker-Azmitia, P. M., and Azmitia, E. C. (1994b). Neuro-glial neurotrophic interaction in the S-100 beta retarded mutant mouse (Polydactyly Nagoya). II. Co-cultures study. Brain Res. 633, 284-288.
431. Ueda, S., Kokotos Leonardt, E. T., Bell, J., III, and Azmitia, E. C. (1995). Serotonergic sprouting into transplanted C-6 gliomas is blocked by S-100 beta antisense gene. Brain Res. Mol. Brain Res. 29, 365-368.
432. Vaidya, V. A., Terwilliger, R. M., and Duman, R. S. (1999). Role of 5-HT2A receptors in the stress-induced down-regulation of brain-derived neurotrophic factor expression in rat hippocampus. Neurosci. Lett. 262, 1-4.
433. van Os, J., Takei, N., Castle, D. J., Wessely, S., Der, G., and Murray, R. M. (1995). Premorbid abnormalities in mania, schizomania, acute schizophrenia and chronic schizophrenia. Soc. Pychiat. Pychiat. Epidemiol. 30, 274-278.
434. van Riel, E., Meijer, O. C., Veenema, A. H., and Joels, M. (2002). Hippocampal serotonin responses in short and long attack latency mice. J. Neuroendocrinol. 14, 234-239.
435. Vitalis, T., Cases, O., Callebert, J., Launay, J. M., Price, D. J., Seif, I., and Gaspar, P. (1998). Effects of monoamine oxidase A inhibition on barrel formation in the mouse somatosensory cortex: Determination of a sensitive developmental period. J. Comp. Neurol. 393, 169-184.
436. Vollenweider, F. X., and Geyer, M. A. (2001). A systems model of altered consciousness: Integrating natural and drug-induced psychoses. Brain Res. Bull. 56, 495-507.
437. Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F., Babler, A., Vogel, H., and Hell, D. (1998). Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport 9, 3897-3902.
438. Vu, D. H., and Tork, I. (1992). Differential development of the dual serotoninergic fiber system in the cerebral cortex of the cat. J. Comp. Neurol. 317, 156-174.
439. Wajda, I. J., Banay-Schwartz, M., Manigault, I., and Lajtha, A. (1986). Modulation of the serotonin S2-receptor in brain after chronic lithium. Neurochem. Res. 11, 949-957.
440. Wallace, J. A., and Lauder, J. M. (1983). Development of the serotonergic system in the rat embryo: An immunocytochemical study. Brain Res. Bull. 10, 459-479.
441. Wang, S. J., Cheng, L. L., and Gean, P. W. (1999). Cross-modulation of synaptic plasticity by beta-adrenergic and 5-HT1A receptors in the rat basolateral amygdala. J. Neurosci. 19, 570-577.
442. Wang, Y., Gu, Q., and Cynader, M. S. (1997). Blockade of serotonin-2C receptors by mesulergine reduces ocular dominance plasticity in kitten visual cortex. Exp. Brain Res. 114, 321-328.
443. Watanabe, Y., Sakai, R. R., McEwen, B. S., and Mendelson, S. (1993). Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin. Brain Res. 615, 87-94.
444. Waxham, M. N., Grotta, J. C., Silva, A. J., Strong, R., and Aronowski, J. (1996). Ischemia-induced neuronal damage: A role for calcium/calmodulin- dependent protein kinase II. J. Cereb Blood Row Metab. 16, 1-6.
445. Wechsler, J. G. (1998). Drug treatment of obesity. Acta Med. Aust. 25, 138-141.
446. Weinberger, D. R. (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Pychiat. 44, 660-669.
447. Weinberger, D. R. (1995). From neuropathology to neurodevelopment. Lancet 346, 552-557.
448. Weinberger, D. R. (1999). Cell biology of the hippocampal formation in schizophrenia. Biol. Pychiat. 45, 395-402.
449. Weinberger, D. R., and Berman, K. F. (1996). Prefrontal function in schizophrenia: Confounds and controversies. Phil. Trans. R. Soc. Lond. B Biol. Sci. 351, 1495-1503.
450. Weissman, N. J. (2001). Appetite suppressants and valvular heart disease. Am. J. Med. Sci. 321, 285-291.
451. Whitaker-Azmitia, P., Zhou, F., Hobin, J., and Borella, A. (2000). Isolation-rearing of rats produces deficits as adults in the serotonergic innervation of hippocampus. Peptides 21, 1755-1759.
452. Whitaker-Azmitia, P. M. (1998). Role of the neurotrophic properties of serotonin in the delay of brain maturation induced by cocaine. Ann. N. Y. Acad. Sci. 846, 158-164.
453. Whitaker-Azmitia, P. M. (2001). Serotonin and brain development: Role in human developmental diseases. Brain Res. Bull. 56, 479-185.
454. Whitaker-Azmitia, P. M., Borella, A., and Raio, N. (1995). Serotonin depletion in the adult rat causes loss of the dendritic marker MAP-2: A new animal model of schizophrenia? Neuropychopharmacology 12, 269-272.
455. Whitaker-Azmitia, P. M., Druse, M., Walker, P., and Lauder, J. M. (1996). Serotonin as a developmental signal. Behav. Brain Res. 73, 19-29.
456. Whitaker-Azmitia, P. M., Lauder, J. M., Shemmer, A., and Azmitia, E. C. (1987). Postnatal changes in serotonin receptors following prenatal alterations in serotonin levels: Further evidence for functional fetal serotonin receptors. Brain Res. 430, 285-289.
457. Whitaker-Azmitia, P. M., Molino, L. J., Caruso, J., and Shemer, A. V. (1990). Serotonergic agents restore appropriate decision-making in neonatal rats displaying dopamine D1 receptor-mediated vacillatory behavior. Eur. J. Pharmacol. 180, 305-309.
458. Williams, J., McGuffin, P., Nothen, M., and Owen, M. J. (1997). Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia. EMASS Collaborative Group. European Multicentre Association Study of Schizophrenia. Lancet 349, 1221.
459. Williams, J., Spurlock, G., McGuffin, P., Mallet, J., Nothen, M. M., Gill, M., Aschauer, H., Nylander, P. O., Macciardi, K., and Owen, M. J. (1996). Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group. Lancet 347, 1294-1296.
460. Wilson, C. C., Faber, K. M., and Haring, J. H. (1998). Serotonin regulates synaptic connections in the dentate molecular layer of adult rats via 5-HT1a receptors: Evidence for a glial mechanism. Brain Res. 782, 235-239.
461. Wissink, S., Meijer, O., Pearce, D., van Der Burg, B., and van Der Saag, P. T. (2000). Regulation of the rat serotonin-1A receptor gene by corticosteroids. J. Biol. Chem. 275, 1321-1326.
462. Woods, B. T. (1998). Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism Am. J. Pychiatr. 155, 1661-1670.
463. Wright, I. C., Rabe-Hesketh, S., Woodruff, P. W., David, A. S., Murray, R. M., and Bullmore, E. T. (2000). Meta-analysis of regional brain volumes in schizophrenia. Am. J. Pychiat. 157, 16-25.
464. Wu, C., Singh, S. K., Dias, P., Kumar, S., and Mann, D. M. (1999). Activated astrocytes display increased 5-HT2a receptor expression in pathological states. Exp. Neurol. 158, 529-533.
465. Yamashita, Y., Ito, T., Hashimoto, I., Ohyama, A., and Kuriyama, K. (1989). Changes in cerebral level of monoamines by Japanese encephalitis virus infection. Uirusu 39, 47-54.
466. Van, Q. S., Jobe, P. C., Cheong, J. H., Ko, K. H., and Dailey, J. W. (1994). Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. N-S Arch. Pharmacol. 350, 149-152.
467. Van, W., Wilson, C. C., and Haring, J. H. (1997a). 5-HT1a receptors mediate the neurotrophic effect of serotonin on developing dentate granule cells. Brain Res. Dev. Brain Res. 98, 185-190.
468. Yan, W., Wilson, G. C., and Haring, J. H. (1997b). Effects of neonatal serotonin depletion on the development of rat dentate granule cells. Brain Res. Dev. Brain Res. 98, 177-184.
469. Yang, Y., and Schmitt, H. P. (2001). Frontotemporal dementia: Evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method. Acta Neuropathol. (Berl.) 101, 256-270.
470. Yates, M., Leake, A., Candy, J. M., Fairbairn, A. F., McKeith, I. G., and Ferner, I. N. (1990). 5HT2 receptor changes in major depression. Biol. Pychiat. 27, 489-496.
471. Yavarone, M. S., Shuey, D. L., Tamir, H., Sadler, T. W., and Lauder, J. M. (1993). Serotonin and cardiac morphogenesis in the mouse embryo. Teratology 47, 573-584.
472. Yocca, F. D., Eison, A. S., Hyslop, D. K., Ryan, E., Taylor, D. P., and Gianutsos, G. (1991). Unique modulation of central 5-HT2 receptor binding sites and 5-HT2 receptor-mediate9 behavior by continuous gepirone treatment. Life Sci. 49, 1777-1785.
473. Yocca, F. D., Wright, R. N., Margraf, R. R., and Eison, A. S. (1990). 8-OH-DPAT and buspirone analogs inhibit the ketanserin-sensitive quipazine-induced head shake response in rats. Pharmacol. Biochem. Behav. 35, 251-254.
474. Young, K. A., Manaye, K. F., Liang, C., Hicks, P. B., and German, D. C. (2000). Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biol. Pychiat. 47, 944-953.
475. Zhang, Z. W. (2003). Serotonin induces tonic firing in layer V pyramidal neurons of rat prefrontal cortex during postnatal development. J. Neurosci. 23, 3373-3384.
476. Zhou, F. C., Sari, Y., Zhang, J. K., Goodlett, C. R., and Li, T. (2001). Prenatal alcohol exposure retards the migration and development of serotonin neurons in fetal C57BL mice. Brain Res. Dev Brain Res. 126, 147-155.
477. Zilles, K., Wu, J., Crusio, W. E., and Schwegler, H. (2000). Water maze and radial maze learning and the density of binding sites of glutamate, GABA, and serotonin receptors in the hippocampus of inbred mouse strains. Hippocampus 10, 213-225.